{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/om300394v.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>The transmetalation reaction between zinc dithiocarbamates\nand rhenium carbonyls has been used as a new strategy to link biomolecules\nto transition metals. The zinc(II) dithiocarbamate of isonipecotic\nacid (<bold>1</bold>) and the succinimidyl ester derivative (<bold>2</bold>) were prepared by straightforward procedures and were fully\ncharacterized by spectroscopic and X-ray diffraction methods, showing\nin both cases the presence of dinuclear complexes. Complex <bold>2</bold> reacted with all the primary and secondary amines studied (glycine\nmethyl ester, \u03b2-alanine methyl ester, 1-(2-methoxyphenyl)piperazine,\nand <sc>d</sc>-(+)-glucosamine) through the activated succinimidyl\nester group, linking the metallic fragment with the biomolecule by\nthe formation of a peptidic bond and leading to the respective bioconjugated\nzinc complexes <bold>3</bold>\u2013<bold>6</bold>. In all cases,\nthese zinc complexes could be isolated from the reaction medium by\nsimple precipitation. These results evidence the potential of complex <bold>2</bold> to be used as a synthon to link the zinc dithiocarbamate\nfragment to biomolecules that contain an amine group. Complexes <bold>3</bold>\u2013<bold>6</bold> were characterized by the usual spectroscopic\nmethods, and all data agree with the proposed structures, which do\nnot contain significant interactions between the zinc fragment and\nthe functional groups of these biomolecules. The transmetalation reaction\nbetween the zinc complexes <bold>3</bold>\u2013<bold>6</bold> and\nthe rhenium carbonyl [ReBr<sub>3</sub>(CO)<sub>3</sub>]<sup>2\u2013</sup> led to the expected rhenium dithiocarbamates <bold>7</bold>\u2013<bold>10</bold> with no change in the organic dithiocarbamate fragments,\nconfirming the viability of this reaction as a tool for linking biomolecules\nto transition elements. All complexes were characterized by spectroscopic\nmethods, and the crystal structure of <bold>8</bold> was studied by\nX-ray diffraction analysis. All data demonstrated that the biomolecule\nis positioned far away from the <italic toggle=\"yes\">fac</italic>-{Re(CO)<sub>3</sub>} fragment, and the octahedral coordination around the metal is completed\nby the functionalized dithiocarbamate and a phosphine ligand. Finally,\nanalysis by ESI-MS spectrometry of the reaction between the zinc complex <bold>4</bold> and a water solution of [Re(H<sub>2</sub>O)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup> at a very low concentration (10 ppm) showed\nthat the transmetalation reaction took place, even though the solubility\nof the zinc complex in water medium was as low as 0.66 ppm. This preliminary\nresult supports the viability of this approach for the preparation\nof rhenium and technetium target-specific radiopharmaceuticals, since\nthe preparations of these compounds are always performed in water\nmedium.</p>", "clean_text": "The transmetalation reaction between zinc dithiocarbamates and rhenium carbonyls has been used as a new strategy to link biomolecules to transition metals. The zinc(II) dithiocarbamate of isonipecotic acid (1) and the succinimidyl ester derivative (2) were prepared by straightforward procedures and were fully characterized by spectroscopic and X-ray diffraction methods, showing in both cases the presence of dinuclear complexes. Complex 2 reacted with all the primary and secondary amines studied (glycine methyl ester, \u03b2-alanine methyl ester, 1-(2-methoxyphenyl)piperazine, and d-(+)-glucosamine) through the activated succinimidyl ester group, linking the metallic fragment with the biomolecule by the formation of a peptidic bond and leading to the respective bioconjugated zinc complexes 3-6. In all cases, these zinc complexes could be isolated from the reaction medium by simple precipitation. These results evidence the potential of complex 2 to be used as a synthon to link the zinc dithiocarbamate fragment to biomolecules that contain an amine group. Complexes 3-6 were characterized by the usual spectroscopic methods, and all data agree with the proposed structures, which do not contain significant interactions between the zinc fragment and the functional groups of these biomolecules. The transmetalation reaction between the zinc complexes 3-6 and the rhenium carbonyl [ReBr3(CO)3]2- led to the expected rhenium dithiocarbamates 7-10 with no change in the organic dithiocarbamate fragments, confirming the viability of this reaction as a tool for linking biomolecules to transition elements. All complexes were characterized by spectroscopic methods, and the crystal structure of 8 was studied by X-ray diffraction analysis. All data demonstrated that the biomolecule is positioned far away from the fac-{Re(CO)3} fragment, and the octahedral coordination around the metal is completed by the functionalized dithiocarbamate and a phosphine ligand. Finally, analysis by ESI-MS spectrometry of the reaction between the zinc complex 4 and a water solution of [Re(H2O)3(CO)3]+ at a very low concentration (10 ppm) showed that the transmetalation reaction took place, even though the solubility of the zinc complex in water medium was as low as 0.66 ppm. This preliminary result supports the viability of this approach for the preparation of rhenium and technetium target-specific radiopharmaceuticals, since the preparations of these compounds are always performed in water medium.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Transmetalation is one of the basic reactions\nin inorganic chemistry that is defined as the exchange of ligands\nbetween two metal atoms. It has been used since the beginnings of\norganometallic chemistry as a practical tool to prepare new compounds,\nbeing based on the substitution of a weak carbon\u2013metal bond\nsuch as Hg\u2013C by a stronger bond such as Zn\u2013C. Currently, this reaction continues to be extremely\nuseful in the synthesis of new compounds, and one pertinent example\nis the use of silver N-heterocyclic carbenes (NHCs) for the preparation\nof transition-metal carbenes.\n</p>", "clean_text": "Introduction\n\nTransmetalation is one of the basic reactions in inorganic chemistry that is defined as the exchange of ligands between two metal atoms. It has been used since the beginnings of organometallic chemistry as a practical tool to prepare new compounds, being based on the substitution of a weak carbon-metal bond such as Hg-C by a stronger bond such as Zn-C. Currently, this reaction continues to be extremely useful in the synthesis of new compounds, and one pertinent example is the use of silver N-heterocyclic carbenes (NHCs) for the preparation of transition-metal carbenes. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": ["else"], "content": "<p>The\nuse of organometallics in biology and medicine, and particularly the\nsearch for organometallic pharmaceuticals, has become a relevant research\ntopic in the last few decades. In this\ncontext, the goal of this study is to apply the transmetalation reaction\nto improve the preparation of organometallic radiopharmaceuticals\nfor nuclear medicine applications. The transmetalation reaction is\ncurrently employed in radiopharmacy to produce the organometallic\ncompound (<sup>99m</sup>Tc)sestamibi. However,\nin our proposal we use this reaction innovatively for a very different\ngoal.</p>", "clean_text": "The use of organometallics in biology and medicine, and particularly the search for organometallic pharmaceuticals, has become a relevant research topic in the last few decades. In this context, the goal of this study is to apply the transmetalation reaction to improve the preparation of organometallic radiopharmaceuticals for nuclear medicine applications. The transmetalation reaction is currently employed in radiopharmacy to produce the organometallic compound (99mTc)sestamibi. However, in our proposal we use this reaction innovatively for a very different goal.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>Molecular imaging methods are useful in medicine because\nthey allow the visualization of biochemical processes in living organisms\nand can help the diagnosis of some diseases by noninvasive techniques.\nThe labeling of biologically active molecules with a radionuclide\nis currently a topic of great interest in radiopharmacy, because it\ncan lead to specific tracers with potential new applications in oncology, infection imaging, neuroreceptor imaging, and other medical specialties. Depending on the emission properties\nof the radionuclide, either of two imaging methods can be used: positron\nemission tomography (PET) or single photon emission computed tomography\n(SPECT). The radionuclide mainly used for SPECT is <sup>99m</sup>Tc, which gives rise to a wide range of radiopharmaceuticals by simple\npreparation procedures and is easily accessible by <sup>99</sup>Mo/<sup>99m</sup>Tc generators.</p>", "clean_text": "Molecular imaging methods are useful in medicine because they allow the visualization of biochemical processes in living organisms and can help the diagnosis of some diseases by noninvasive techniques. The labeling of biologically active molecules with a radionuclide is currently a topic of great interest in radiopharmacy, because it can lead to specific tracers with potential new applications in oncology, infection imaging, neuroreceptor imaging, and other medical specialties. Depending on the emission properties of the radionuclide, either of two imaging methods can be used: positron emission tomography (PET) or single photon emission computed tomography (SPECT). The radionuclide mainly used for SPECT is 99mTc, which gives rise to a wide range of radiopharmaceuticals by simple preparation procedures and is easily accessible by 99Mo/99mTc generators.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "text", "classification": ["else"], "content": "<p>Furthermore, organometallic radiopharmaceutical\nchemistry has been greatly stimulated in recent years after the development\nof simple and convenient preparations of the aqua ions <italic toggle=\"yes\">fac</italic>-[<sup>99m</sup>Tc(H<sub>2</sub>O)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup> and <italic toggle=\"yes\">fac</italic>-[<sup>188</sup>Re(H<sub>2</sub>O)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup>. The labile properties of water\nligands in these cations permit the straightforward preparation of\nnew rhenium and technetium radiopharmaceuticals with carbonyl ligands,\nwhich exhibit small size, high thermodynamic stability, kinetic inertia,\nand high in vivo stability. All these\nproperties make the <italic toggle=\"yes\">fac</italic>-{M(CO)<sub>3</sub>} fragment\n(M = Tc, Re) an excellent synthon for developing new specific tracers\nwith biologically active molecules. Therefore, most of the current\nresearch work with this metal carbonyl is oriented toward the development\nof new bioconjugated compounds. However,\nthere are some difficulties that are inherent to the preparation of\nspecific tracers with <sup>99m</sup>Tc carbonyls. A problematic point\nregarding the preparation of such compounds for radiopharmaceutical\napplication is shown schematically in Figure .</p>", "clean_text": "Furthermore, organometallic radiopharmaceutical chemistry has been greatly stimulated in recent years after the development of simple and convenient preparations of the aqua ions fac-[99mTc(H2O)3(CO)3]+ and fac-[188Re(H2O)3(CO)3]+. The labile properties of water ligands in these cations permit the straightforward preparation of new rhenium and technetium radiopharmaceuticals with carbonyl ligands, which exhibit small size, high thermodynamic stability, kinetic inertia, and high in vivo stability. All these properties make the fac-{M(CO)3} fragment (M = Tc, Re) an excellent synthon for developing new specific tracers with biologically active molecules. Therefore, most of the current research work with this metal carbonyl is oriented toward the development of new bioconjugated compounds. However, there are some difficulties that are inherent to the preparation of specific tracers with 99mTc carbonyls. A problematic point regarding the preparation of such compounds for radiopharmaceutical application is shown schematically in Figure .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 6, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Schematic representation of the competition between labeled and unlabeled\nmolecules for receptor sites after a labeling reaction.</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Schematic representation of the competition between labeled and unlabeled molecules for receptor sites after a labeling reaction.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<p>Since the concentration of radioactive metal in\nthe labeling reactions is very low (10<sup>\u20137</sup>\u201310<sup>\u20138</sup> M), only a very small portion of functionalized biomolecules\nare in fact labeled with the metal carbonyl fragment (functionalized\nbiomolecules have the ability to bond to the metal fragment, as is\nshown in the figure). Consequently, in the radiopharmaceutical preparation\nthe ratio of labeled to unlabeled biomolecules is very low, meaning\nthat the labeled biomolecules must compete with unlabeled biomolecules\nfor the receptor sites. In order to improve\nthe ratio of labeled to unlabeled biomolecules in radiopharmaceutical\npreparations, we have designed a new approach that allows two apparently\ncontradictory objectives: (1) a high labeling yield (nearly all radioactive\nmetals should be linked to the biomolecule) and (2) a low unlabeled\nbiomolecule concentration in the reaction mixture. This new strategy\nis based on using a transmetalation reaction between a zinc complex\nof the functionalized biomolecule which is sparingly soluble in water\nand the radioactive metal in water solution (Scheme ).</p>", "clean_text": "Since the concentration of radioactive metal in the labeling reactions is very low (10-7-10-8 M), only a very small portion of functionalized biomolecules are in fact labeled with the metal carbonyl fragment (functionalized biomolecules have the ability to bond to the metal fragment, as is shown in the figure). Consequently, in the radiopharmaceutical preparation the ratio of labeled to unlabeled biomolecules is very low, meaning that the labeled biomolecules must compete with unlabeled biomolecules for the receptor sites. In order to improve the ratio of labeled to unlabeled biomolecules in radiopharmaceutical preparations, we have designed a new approach that allows two apparently contradictory objectives: (1) a high labeling yield (nearly all radioactive metals should be linked to the biomolecule) and (2) a low unlabeled biomolecule concentration in the reaction mixture. This new strategy is based on using a transmetalation reaction between a zinc complex of the functionalized biomolecule which is sparingly soluble in water and the radioactive metal in water solution (Scheme ).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 8, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0005.tif\"></graphic>\n</fig>", "clean_text": " 1  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 9, "type": "text", "classification": ["else"], "content": "<p>This reaction is shifted to the right by the\nhigher thermodynamic stability of bonds with the {M(CO)<sub>3</sub>} fragment (M = Tc, Re) with respect to the zinc atom. Concurrently,\nthe concentration of unlabeled biomolecule in the reaction mixture\ncan be very low because it is limited by the low solubility of the\nbioconjugate zinc compound in water.</p>", "clean_text": "This reaction is shifted to the right by the higher thermodynamic stability of bonds with the {M(CO)3} fragment (M = Tc, Re) with respect to the zinc atom. Concurrently, the concentration of unlabeled biomolecule in the reaction mixture can be very low because it is limited by the low solubility of the bioconjugate zinc compound in water.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 10, "type": "text", "classification": ["else"], "content": "<p>To this purpose, we designed\na new compound based on a derivative of isonipecotic acid (Scheme ) as a key compound in attaining our goal, given\nits following advantages.<list list-type=\"label\">\n<list-item>\n<label>(1)</label>\n<p>The dithiocarbamate of isonipecotic\nacid has been reported. It displays an\nappropriate structure for our purposes because it can lead to very\nstable, symmetric compounds, since the amine group in isonipecotic\nacid is a symmetric secondary amine.</p>\n</list-item>\n<list-item>\n<label>(2)</label>\n<p>Zinc dithiocarbamates are stable compounds that exhibit transmetalation reactions with transition metals. Therefore, a zinc dithiocarbamate\nwith the structure shown in Scheme  can be\nuseful for the transmetalation reaction displayed in Scheme .</p>\n</list-item>\n<list-item>\n<label>(3)</label>\n<p>The above structure contains an <italic toggle=\"yes\">N</italic>-hydroxysuccinimidyl\nester group suitable for coupling reactions with amines in order to\nlink the metal to a biomolecule. Hence,\nthis dithiocarbamate of isonipecotic acid can act as a bifunctional\nchelating agent (BFCA) because it can\nwork as a linker between the metal (bonded to the dithiocarbamate\nfunction) and the biomolecule (bonded by a peptidic bond).</p>\n</list-item>\n<list-item>\n<label>(4)</label>\n<p>It is expected that the\nzinc dithiocarbamate derivative of isonipecotic acid will show low\ntoxicity. Indeed, isonipecotic acid and\nzinc dithiocarbamates are involved in\npharmacological studies and the dithiocarbamate of isonipecotic acid\nexhibits anti-inflammatory activity.\n</p>\n</list-item>\n</list>\n</p>", "clean_text": "To this purpose, we designed a new compound based on a derivative of isonipecotic acid (Scheme ) as a key compound in attaining our goal, given its following advantages.  (1) The dithiocarbamate of isonipecotic acid has been reported. It displays an appropriate structure for our purposes because it can lead to very stable, symmetric compounds, since the amine group in isonipecotic acid is a symmetric secondary amine.   (2) Zinc dithiocarbamates are stable compounds that exhibit transmetalation reactions with transition metals. Therefore, a zinc dithiocarbamate with the structure shown in Scheme  can be useful for the transmetalation reaction displayed in Scheme .   (3) The above structure contains an N-hydroxysuccinimidyl ester group suitable for coupling reactions with amines in order to link the metal to a biomolecule. Hence, this dithiocarbamate of isonipecotic acid can act as a bifunctional chelating agent (BFCA) because it can work as a linker between the metal (bonded to the dithiocarbamate function) and the biomolecule (bonded by a peptidic bond).   (4) It is expected that the zinc dithiocarbamate derivative of isonipecotic acid will show low toxicity. Indeed, isonipecotic acid and zinc dithiocarbamates are involved in pharmacological studies and the dithiocarbamate of isonipecotic acid exhibits anti-inflammatory activity.    ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 11, "type": "text", "classification": ["else"], "content": "<p>The dithiocarbamate of isonipecotic\nacid has been reported. It displays an\nappropriate structure for our purposes because it can lead to very\nstable, symmetric compounds, since the amine group in isonipecotic\nacid is a symmetric secondary amine.</p>", "clean_text": "The dithiocarbamate of isonipecotic acid has been reported. It displays an appropriate structure for our purposes because it can lead to very stable, symmetric compounds, since the amine group in isonipecotic acid is a symmetric secondary amine.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<p>Zinc dithiocarbamates are stable compounds that exhibit transmetalation reactions with transition metals. Therefore, a zinc dithiocarbamate\nwith the structure shown in Scheme  can be\nuseful for the transmetalation reaction displayed in Scheme .</p>", "clean_text": "Zinc dithiocarbamates are stable compounds that exhibit transmetalation reactions with transition metals. Therefore, a zinc dithiocarbamate with the structure shown in Scheme  can be useful for the transmetalation reaction displayed in Scheme .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 13, "type": "text", "classification": ["else"], "content": "<p>The above structure contains an <italic toggle=\"yes\">N</italic>-hydroxysuccinimidyl\nester group suitable for coupling reactions with amines in order to\nlink the metal to a biomolecule. Hence,\nthis dithiocarbamate of isonipecotic acid can act as a bifunctional\nchelating agent (BFCA) because it can\nwork as a linker between the metal (bonded to the dithiocarbamate\nfunction) and the biomolecule (bonded by a peptidic bond).</p>", "clean_text": "The above structure contains an N-hydroxysuccinimidyl ester group suitable for coupling reactions with amines in order to link the metal to a biomolecule. Hence, this dithiocarbamate of isonipecotic acid can act as a bifunctional chelating agent (BFCA) because it can work as a linker between the metal (bonded to the dithiocarbamate function) and the biomolecule (bonded by a peptidic bond).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 14, "type": "text", "classification": ["else"], "content": "<p>It is expected that the\nzinc dithiocarbamate derivative of isonipecotic acid will show low\ntoxicity. Indeed, isonipecotic acid and\nzinc dithiocarbamates are involved in\npharmacological studies and the dithiocarbamate of isonipecotic acid\nexhibits anti-inflammatory activity.\n</p>", "clean_text": "It is expected that the zinc dithiocarbamate derivative of isonipecotic acid will show low toxicity. Indeed, isonipecotic acid and zinc dithiocarbamates are involved in pharmacological studies and the dithiocarbamate of isonipecotic acid exhibits anti-inflammatory activity. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 15, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0006.tif\"></graphic>\n</fig>", "clean_text": " 2  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 16, "type": "text", "classification": ["else"], "content": "<title>Results and Discussion</title><title>Zinc(II) Dithiocarbamate of Isonipecotic Acid (<bold>1</bold>)</title><p>This compound was prepared by the reaction between a solution\nof the sodium dithiocarbamate of isonipecotate prepared \u201cin\nsitu\u201d from the amine and a water\nsolution of zinc(II) acetate (Scheme ). Complex <bold>1</bold> was obtained in high yield (84%) and high purity by simple\ncrystallization from the reaction medium. One interesting aspect is\nthat this compound is scarcely soluble in water and, as was stated\nin the , the low solubility of\nzinc compounds may be useful to improve the labeled/unlabeled ratio\nin radiopharmaceutical preparation. Thus, the compound was characterized\nby NMR spectroscopy in D<sub>2</sub>O but all spectra were recorded\nat a temperature of 40 \u00b0C in order to improve the solubility\nof <bold>1</bold>. All spectroscopic data agree with the proposed\nstructure. For instance, the characteristic signals of the dithiocarbamate\ngroup observed in the <sup>13</sup>C NMR (201.8 ppm) and the IR spectra\n(1493 cm<sup>\u20131</sup>, \u03bd(C\ue5fbN)) are consistent\nwith reported data for bidentate metal dithiocarbamates. The presence of the isonipecotic fragment is\nevidenced by the <sup>1</sup>H NMR spectrum, in which all observed\nsignals could be assigned to the hydrogen atoms of the heterocycle\nby means of 2D experiments (COSY, HSQC, and NOESY), and these assignments\nagree with reported data for isonipecotic acid.\n</p>", "clean_text": "Results and Discussion\n\nZinc(II) Dithiocarbamate of Isonipecotic Acid (1)\n\nThis compound was prepared by the reaction between a solution of the sodium dithiocarbamate of isonipecotate prepared \"in situ\" from the amine and a water solution of zinc(II) acetate (Scheme ). Complex 1 was obtained in high yield (84%) and high purity by simple crystallization from the reaction medium. One interesting aspect is that this compound is scarcely soluble in water and, as was stated in the , the low solubility of zinc compounds may be useful to improve the labeled/unlabeled ratio in radiopharmaceutical preparation. Thus, the compound was characterized by NMR spectroscopy in D2O but all spectra were recorded at a temperature of 40 \u00b0C in order to improve the solubility of 1. All spectroscopic data agree with the proposed structure. For instance, the characteristic signals of the dithiocarbamate group observed in the 13C NMR (201.8 ppm) and the IR spectra (1493 cm-1, \u03bd(C\ue5fbN)) are consistent with reported data for bidentate metal dithiocarbamates. The presence of the isonipecotic fragment is evidenced by the 1H NMR spectrum, in which all observed signals could be assigned to the hydrogen atoms of the heterocycle by means of 2D experiments (COSY, HSQC, and NOESY), and these assignments agree with reported data for isonipecotic acid. ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0007.tif\"></graphic>\n</fig>", "clean_text": " 3  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 18, "type": "text", "classification": "error", "content": "<p>The crystal structure of <bold>1</bold> (Figure ) shows the formation of the postulated zinc dithiocarbamate\nbut also reveals that it is a dinuclear centrosymmetric\ncompound in the solid state. This is a common arrangement for zinc\ndithiocarbamates, although monomeric\ncompounds have also been reported. The\nanalysis of this structure shows that bond distances and angles of\nthe core {Zn<sub>2</sub>S<sub>8</sub>} are very similar to previously\nreported data for dinuclear zinc dithiocarbamates with simple alkyl\ngroups such as ethyl and isopropyl. The geometry around the zinc atom is intermediate\nbetween trigonal bipyramidal and tetragonal pyramidal, with four similar\nZn\u2013S distances (Zn\u2013S21 = 2.3433(5) \u00c5, Zn\u2013S12\n= 2.3457(6) \u00c5, Zn\u2013S22<sup>i</sup> = 2.3972(5) \u00c5,\nZn\u2013S11 = 2.4780(5) \u00c5; i denotes an equivalent atom by\nan inversion center), whereas one Zn\u2013S bond is significantly\nlonger (Zn\u2013S22 = 2.8162(5) \u00c5). Similar values have been\nreported for zinc diethyldithiocarbamate (2.331, 2.355, 2.383, 2.443,\n2.815 \u00c5) and zinc diisopropyldithiocarbamate\n(2.335, 2.342, 2.377, 2.454, 2.815 \u00c5).\n</p>", "clean_text": "The crystal structure of 1 (Figure ) shows the formation of the postulated zinc dithiocarbamate but also reveals that it is a dinuclear centrosymmetric compound in the solid state. This is a common arrangement for zinc dithiocarbamates, although monomeric compounds have also been reported. The analysis of this structure shows that bond distances and angles of the core {Zn2S8} are very similar to previously reported data for dinuclear zinc dithiocarbamates with simple alkyl groups such as ethyl and isopropyl. The geometry around the zinc atom is intermediate between trigonal bipyramidal and tetragonal pyramidal, with four similar Zn-S distances (Zn-S21 = 2.3433(5) \u00c5, Zn-S12 = 2.3457(6) \u00c5, Zn-S22i = 2.3972(5) \u00c5, Zn-S11 = 2.4780(5) \u00c5; i denotes an equivalent atom by an inversion center), whereas one Zn-S bond is significantly longer (Zn-S22 = 2.8162(5) \u00c5). Similar values have been reported for zinc diethyldithiocarbamate (2.331, 2.355, 2.383, 2.443, 2.815 \u00c5) and zinc diisopropyldithiocarbamate (2.335, 2.342, 2.377, 2.454, 2.815 \u00c5). ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 19, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Perspective\nview of the centrosymmetric dimeric anion [Zn<sub>2</sub>(S<sub>2</sub>CNC<sub>5</sub>H<sub>9</sub>COO)<sub>4</sub>]<sup>4\u2013</sup> of complex <bold>1</bold>. Hydrogen atoms have been omitted for\nclarity.</p>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  Perspective view of the centrosymmetric dimeric anion [Zn2(S2CNC5H9COO)4]4- of complex 1. Hydrogen atoms have been omitted for clarity.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 20, "type": "text", "classification": ["else"], "content": "<title>Succinimidyl Ester of Zinc(II) Dithiocarbamate of Isonipecotic\nAcid (<bold>2</bold>)</title><p>Although the preparation of succinimidyl\nester derivatives from carboxylic acid is a well-known process, in\nmost synthetic pathways reported the starting reagent is carboxylic\nacid; this route is not feasible in our case, since dithiocarbamates\nare not stable in acidic medium. This problem was solved by using\nthe peptide coupling reagent TSTU (<italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>\u2032,<italic toggle=\"yes\">N</italic>\u2032-tetramethyl-<italic toggle=\"yes\">O</italic>-(<italic toggle=\"yes\">N</italic>-succinimidyl)uronium tetrafluoroborate;\nCAS 105832-38-0), since it can react directly with the carboxylate\ngroup and it avoids working in acid media (Scheme ). Furthermore, the preparation procedure by this way is very\nstraightforward and convenient because compound <bold>2</bold> can\nbe isolated from the dimethylformamide reaction medium by simple precipitation\nafter addition of an ethanol/water mixture, allowing us to obtain <bold>2</bold> in high yield (above 95%) and purity.</p>", "clean_text": "Succinimidyl Ester of Zinc(II) Dithiocarbamate of Isonipecotic Acid (2)\n\nAlthough the preparation of succinimidyl ester derivatives from carboxylic acid is a well-known process, in most synthetic pathways reported the starting reagent is carboxylic acid; this route is not feasible in our case, since dithiocarbamates are not stable in acidic medium. This problem was solved by using the peptide coupling reagent TSTU (N,N,N',N'-tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate; CAS 105832-38-0), since it can react directly with the carboxylate group and it avoids working in acid media (Scheme ). Furthermore, the preparation procedure by this way is very straightforward and convenient because compound 2 can be isolated from the dimethylformamide reaction medium by simple precipitation after addition of an ethanol/water mixture, allowing us to obtain 2 in high yield (above 95%) and purity.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0008.tif\"></graphic>\n</fig>", "clean_text": " 4  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "text", "classification": ["else"], "content": "<p>Spectroscopic data of <bold>2</bold> are fully\nconsistent with the proposed structure. Thus, ESI-MS shows a molecular\nweight increase due to the formation of the succinimidyl ester group\nand NMR spectroscopy displays all signals of the succinimidyl fragment,\nas well as the shift of resonances of the isonipecotic fragment atoms\ncloser to the ester group such as the carbonyl carbon and the hydrogen\nin position 4 of the piperidine ring. Single crystals of <bold>2</bold> could be obtained by recrystallization from acetonitrile. The X-ray\ndiffraction analysis corroborated the proposed structure, represented\nin Figure .</p>", "clean_text": "Spectroscopic data of 2 are fully consistent with the proposed structure. Thus, ESI-MS shows a molecular weight increase due to the formation of the succinimidyl ester group and NMR spectroscopy displays all signals of the succinimidyl fragment, as well as the shift of resonances of the isonipecotic fragment atoms closer to the ester group such as the carbonyl carbon and the hydrogen in position 4 of the piperidine ring. Single crystals of 2 could be obtained by recrystallization from acetonitrile. The X-ray diffraction analysis corroborated the proposed structure, represented in Figure .", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Perspective view of the centrosymmetric\ndimeric complex <bold>2</bold>. Hydrogen atoms have been omitted for\nclarity.</p>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  Perspective view of the centrosymmetric dimeric complex 2. Hydrogen atoms have been omitted for clarity.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 24, "type": "text", "classification": "error", "content": "<p>When this structure is compared with that of compound <bold>1</bold>, the strong similarity between the {Zn<sub>2</sub>S<sub>8</sub>} cores in both complexes is obvious. This result evidences\nthat the conversion of the carboxylate group in <bold>1</bold> to\nthe corresponding succinimidyl ester has a minimum influence on the\ndithiocarbamate group. The coordination around the zinc atoms is analogous\nin both complexes, with one Zn\u2013S distance being significantly\nlonger than the others (Zn\u2013S distances for <bold>2</bold>:\nZn\u2013S21 = 2.369(2) \u00c5, Zn\u2013S12 = 2. 2.364(3) \u00c5,\nZn\u2013S22<sup>i</sup> = 2.371(2) \u00c5, Zn\u2013S11 = 2.413(2)\n\u00c5, Zn\u2013S22 = 2.753(2) \u00c5; i denotes an equivalent atom\nby an inversion center).</p>", "clean_text": "When this structure is compared with that of compound 1, the strong similarity between the {Zn2S8} cores in both complexes is obvious. This result evidences that the conversion of the carboxylate group in 1 to the corresponding succinimidyl ester has a minimum influence on the dithiocarbamate group. The coordination around the zinc atoms is analogous in both complexes, with one Zn-S distance being significantly longer than the others (Zn-S distances for 2: Zn-S21 = 2.369(2) \u00c5, Zn-S12 = 2. 2.364(3) \u00c5, Zn-S22i = 2.371(2) \u00c5, Zn-S11 = 2.413(2) \u00c5, Zn-S22 = 2.753(2) \u00c5; i denotes an equivalent atom by an inversion center).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 25, "type": "text", "classification": ["else"], "content": "<title>Bioconjugated Zn(II) Dithiocarbamates (<bold>3</bold>\u2013<bold>6</bold>)</title><p>As stated in the , complex <bold>2</bold> was designed with activated ester groups\nwith the aim of preparing bioconjugated compounds by means of a coupling\nreaction with an amine group of a biomolecule. In the first stage,\nwe studied the reaction between <bold>2</bold> and the methyl esters\nof the amino acids glycine and \u03b2-alanine as a test for the application\nof this reaction to the preparation of bioconjugated Zn(II) dithiocarbamates\n(Scheme ).\n</p>", "clean_text": "Bioconjugated Zn(II) Dithiocarbamates (3-6)\n\nAs stated in the , complex 2 was designed with activated ester groups with the aim of preparing bioconjugated compounds by means of a coupling reaction with an amine group of a biomolecule. In the first stage, we studied the reaction between 2 and the methyl esters of the amino acids glycine and \u03b2-alanine as a test for the application of this reaction to the preparation of bioconjugated Zn(II) dithiocarbamates (Scheme ). ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0009.tif\"></graphic>\n</fig>", "clean_text": " 5  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "text", "classification": ["else"], "content": "<p>The NMR analysis of the reaction mixture showed\nthat the reaction of <bold>2</bold> with the methyl esters of glycine\nand \u03b2-alanine is nearly quantitative after a few hours at room\ntemperature. Thus, complexes <bold>3</bold> and <bold>4</bold> could\nbe isolated from the reaction mixture by the simple addition of an\nethanol/water mixture. This very direct procedure gives pure compounds\nthat can be used without recrystallization in subsequent reactions.</p>", "clean_text": "The NMR analysis of the reaction mixture showed that the reaction of 2 with the methyl esters of glycine and \u03b2-alanine is nearly quantitative after a few hours at room temperature. Thus, complexes 3 and 4 could be isolated from the reaction mixture by the simple addition of an ethanol/water mixture. This very direct procedure gives pure compounds that can be used without recrystallization in subsequent reactions.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 28, "type": "text", "classification": ["else"], "content": "<p>Once the viability of this approach was established with the model\ncompounds <bold>3</bold> and <bold>4</bold>, 1-(2-methoxyphenyl)piperazine\nwas chosen as the next reagent to be studied. This amine can be viewed\nas a small biomolecule, because compounds with an arylpiperazine moiety\nare useful for binding to 5-HT<sub>1A</sub>\n serotonergic receptors in the central nervous system and radiopharmaceuticals\nwith this fragment are highly relevant\nfor the study of neuropsychiatric diseases. Furthermore, since this\ncompound is a piperazine derivative, it is useful for testing if the\nability of <bold>2</bold> to react with amines can be extended to\nsecondary amines. Experimental results confirmed this hypothesis,\nand the functionalized zinc dithiocarbamate <bold>5</bold> was prepared\nby following a method as simple as that used for the synthesis of\nthe model compounds <bold>3</bold> and <bold>4</bold>; as was noted\nfor those compounds, <bold>5</bold> was also obtained pure in good\nyield (71%).</p>", "clean_text": "Once the viability of this approach was established with the model compounds 3 and 4, 1-(2-methoxyphenyl)piperazine was chosen as the next reagent to be studied. This amine can be viewed as a small biomolecule, because compounds with an arylpiperazine moiety are useful for binding to 5-HT1A  serotonergic receptors in the central nervous system and radiopharmaceuticals with this fragment are highly relevant for the study of neuropsychiatric diseases. Furthermore, since this compound is a piperazine derivative, it is useful for testing if the ability of 2 to react with amines can be extended to secondary amines. Experimental results confirmed this hypothesis, and the functionalized zinc dithiocarbamate 5 was prepared by following a method as simple as that used for the synthesis of the model compounds 3 and 4; as was noted for those compounds, 5 was also obtained pure in good yield (71%).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 29, "type": "text", "classification": ["else"], "content": "<p>The last compound of this family was prepared by\nreaction between <bold>2</bold> and <sc>d</sc>-(+)-glucosamine to\nyield the bioconjugate dithiocarbamate <bold>6</bold>. This reagent\nwas chosen because obtaining <sup>99m</sup>Tc-glucose derivatives\nis a subject of prime interest, due to the notion that these compounds\ncould be a more readily available and less expensive alternative to <sup>18</sup>\n<italic toggle=\"yes\">F</italic>-2-deoxy-2-fluoro-<sc>d</sc>-glucopyranose\n(FDG), which is currently employed for tumor imaging. As in previous complexes, <bold>6</bold> was also obtained\nas a pure compound by a similarly simple procedure with minor differences\ndue to the different solubilities of glucose derivatives.</p>", "clean_text": "The last compound of this family was prepared by reaction between 2 and d-(+)-glucosamine to yield the bioconjugate dithiocarbamate 6. This reagent was chosen because obtaining 99mTc-glucose derivatives is a subject of prime interest, due to the notion that these compounds could be a more readily available and less expensive alternative to 18 F-2-deoxy-2-fluoro-d-glucopyranose (FDG), which is currently employed for tumor imaging. As in previous complexes, 6 was also obtained as a pure compound by a similarly simple procedure with minor differences due to the different solubilities of glucose derivatives.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 30, "type": "text", "classification": ["else"], "content": "<p>All\nsynthesized compounds were characterized by the usual spectroscopic\nand spectrometric techniques. NMR signals corresponding to the isonipecotic\nfragment were observed in all compounds in positions similar to those\nfound for <bold>2</bold>, the most shifted signal being the resonance\nin <sup>1</sup>H NMR assigned to the hydrogen at position 4 of the\npiperidine ring, which is consistent with the substitution of the\nsuccinimidyl ester located in the same position by the amide group\nin <bold>3</bold>\u2013<bold>6</bold>. In addition, the expected\nsignals of all amide fragments were observed in <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy, as well as the molecular ion peak (M\n+ Na<sup>+</sup>) for the functionalized zinc dithiocarbamates <bold>3</bold>\u2013<bold>6</bold>.</p>", "clean_text": "All synthesized compounds were characterized by the usual spectroscopic and spectrometric techniques. NMR signals corresponding to the isonipecotic fragment were observed in all compounds in positions similar to those found for 2, the most shifted signal being the resonance in 1H NMR assigned to the hydrogen at position 4 of the piperidine ring, which is consistent with the substitution of the succinimidyl ester located in the same position by the amide group in 3-6. In addition, the expected signals of all amide fragments were observed in 1H and 13C NMR spectroscopy, as well as the molecular ion peak (M + Na+) for the functionalized zinc dithiocarbamates 3-6.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 31, "type": "text", "classification": ["else"], "content": "<title>Rhenium Carbonyl Compounds Prepared by Transmetalation Reactions\n(<bold>7</bold>\u2013<bold>10</bold>)</title><p>The transmetalation\nreaction between the functionalized zinc complexes <bold>3</bold>\u2013<bold>6</bold> and rhenium was studied with the carbonyl [ReBr<sub>3</sub>(CO)<sub>3</sub>]<sup>2\u2013</sup>, as shown in Scheme .\n</p><p>This reaction was carried out in methanol, although\nthe solubility of zinc complexes <bold>3</bold>\u2013<bold>6</bold> is very low in this medium. Thus, the fast conversion of suspensions\nof zinc complexes <bold>3</bold>\u2013<bold>6</bold> in methanol\ninto clear solutions after the addition of rhenium carbonyl is indicative\nof the driving force of the transmetalation reaction. <sup>13</sup>C NMR spectroscopy confirms the nearly quantitative character of\nthis reaction, since NMR analysis of the reaction mixture shows the\ncomplete absence of the signal assigned to the carbon atom of a dithiocarbamate\ngroup linked to zinc (\u223c204 ppm) and it displays a downfield-shifted\npeak (\u223c210 ppm) assigned to the dithiocarbamate bonded to rhenium.</p>", "clean_text": "Rhenium Carbonyl Compounds Prepared by Transmetalation Reactions (7-10)\n\nThe transmetalation reaction between the functionalized zinc complexes 3-6 and rhenium was studied with the carbonyl [ReBr3(CO)3]2-, as shown in Scheme . \n\nThis reaction was carried out in methanol, although the solubility of zinc complexes 3-6 is very low in this medium. Thus, the fast conversion of suspensions of zinc complexes 3-6 in methanol into clear solutions after the addition of rhenium carbonyl is indicative of the driving force of the transmetalation reaction. 13C NMR spectroscopy confirms the nearly quantitative character of this reaction, since NMR analysis of the reaction mixture shows the complete absence of the signal assigned to the carbon atom of a dithiocarbamate group linked to zinc (~204 ppm) and it displays a downfield-shifted peak (~210 ppm) assigned to the dithiocarbamate bonded to rhenium.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 32, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0010.tif\"></graphic>\n</fig>", "clean_text": " 6  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 33, "type": "text", "classification": ["else"], "content": "<p>Carbonyl complexes <bold>7</bold>\u2013<bold>10</bold> were characterized\nby the usual spectroscopic and spectrometric techniques. The NMR chemical\nshifts of groups coordinated to rhenium metal are consistent with\nreported data for other [Re(CO)<sub>3</sub>(SS)(P)] complexes, showing the resonances of coordinated phosphine\n(<sup>31</sup>P) and the carbon atom of the dithiocarbamate group\nlinked to rhenium. The signals of the characteristic set of <italic toggle=\"yes\">fac</italic>-{Re(CO)<sub>3</sub>} fragments are displayed in the\nIR spectra, and the molecular peaks (M + Na<sup>+</sup>) are observed\nfor complexes <bold>7</bold>\u2013<bold>10</bold> in ESI-MS spectrometry.\nSpectroscopic data of functional groups linked to dithiocarbamate\nare similar to those of complexes <bold>3</bold>\u2013<bold>6</bold>, showing that the substitution of zinc metal by rhenium has very\nlittle influence on the biomolecular fragment.</p>", "clean_text": "Carbonyl complexes 7-10 were characterized by the usual spectroscopic and spectrometric techniques. The NMR chemical shifts of groups coordinated to rhenium metal are consistent with reported data for other [Re(CO)3(SS)(P)] complexes, showing the resonances of coordinated phosphine (31P) and the carbon atom of the dithiocarbamate group linked to rhenium. The signals of the characteristic set of fac-{Re(CO)3} fragments are displayed in the IR spectra, and the molecular peaks (M + Na+) are observed for complexes 7-10 in ESI-MS spectrometry. Spectroscopic data of functional groups linked to dithiocarbamate are similar to those of complexes 3-6, showing that the substitution of zinc metal by rhenium has very little influence on the biomolecular fragment.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 34, "type": "text", "classification": ["else"], "content": "<p>The crystal structure\nof complex <bold>8</bold> confirms the proposed structure for rhenium\ncomplexes, showing an arrangement very similar to those previously\nreported for other [Re(CO)<sub>3</sub>(SS)(P)] complexes (Figure ). The coordination around rhenium\nmetal can be described as a slightly distorted octahedron, in which\nthe main distortion comes from the chelated dithiocarbamate, which\nforces the S\u2013Re\u2013S angle to be near 70\u00b0.</p>", "clean_text": "The crystal structure of complex 8 confirms the proposed structure for rhenium complexes, showing an arrangement very similar to those previously reported for other [Re(CO)3(SS)(P)] complexes (Figure ). The coordination around rhenium metal can be described as a slightly distorted octahedron, in which the main distortion comes from the chelated dithiocarbamate, which forces the S-Re-S angle to be near 70\u00b0.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 35, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Perspective\nview of complex <bold>8</bold>. Hydrogen atoms have been omitted for\nclarity.</p>\n</caption>\n<graphic id=\"gr11\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  Perspective view of complex 8. Hydrogen atoms have been omitted for clarity.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 36, "type": "text", "classification": "error", "content": "<p>A remarkable detail of complexes <bold>7</bold>\u2013<bold>10</bold> is that two signals of different intensity\nand with similar chemical shifts (separated by 0.4\u20130.6 ppm)\nare observed in the <sup>31</sup>P NMR spectra and an analogous situation\nis detected for some <sup>1</sup>H NMR signals. This phenomenon was\nnot observed in previous studies with other [Re(CO)<sub>3</sub>(SS)(P)]\ncomplexes, and it suggests the presence of two isomers in solution.\nThe shape of this signal evolves with temperature and shows the coalescence\nof the two signals at temperatures of nearly 50 \u00b0C. This result\nis consistent with the existence of two isomers differing in the position\nof the biomolecular fragment linked to the C4 atom of the piperidine\nring (axial or equatorial). The position of this group can be interconverted\nat low temperatures via different mechanisms, such as a rotation around\nthe C\u2013N bond of dithiocarbamate. No separation between the two isomers was possible by HPLC analysis\nof <bold>7</bold>\u2013<bold>10</bold>, and a single peak was always\nobserved. These results support the hypothesis of a fast conversion\nbetween the two isomers that makes their separation unviable.</p>", "clean_text": "A remarkable detail of complexes 7-10 is that two signals of different intensity and with similar chemical shifts (separated by 0.4-0.6 ppm) are observed in the 31P NMR spectra and an analogous situation is detected for some 1H NMR signals. This phenomenon was not observed in previous studies with other [Re(CO)3(SS)(P)] complexes, and it suggests the presence of two isomers in solution. The shape of this signal evolves with temperature and shows the coalescence of the two signals at temperatures of nearly 50 \u00b0C. This result is consistent with the existence of two isomers differing in the position of the biomolecular fragment linked to the C4 atom of the piperidine ring (axial or equatorial). The position of this group can be interconverted at low temperatures via different mechanisms, such as a rotation around the C-N bond of dithiocarbamate. No separation between the two isomers was possible by HPLC analysis of 7-10, and a single peak was always observed. These results support the hypothesis of a fast conversion between the two isomers that makes their separation unviable.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 37, "type": "text", "classification": "error", "content": "<p>Although the reaction between the zinc dithiocarbamates <bold>3</bold>\u2013<bold>6</bold> and the rhenium carbonyl [ReBr<sub>3</sub>(CO)<sub>3</sub>]<sup>2\u2013</sup> confirms the viability of the\ntransmetalation reaction, to take advantage of this approach in radiopharmacy,\nthe reaction must be feasible in aqueous medium. With the aim of exploring\nthis possibility, the reaction of an aqueous solution of [Re(H<sub>2</sub>O)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup> at a very low\nconcentration (10 ppm) with the zinc complex <bold>4</bold> was studied\nas shown in Scheme . Complex <bold>4</bold> and triphenylphosphine were successively added as solid compounds\nto an aqueous solution of [Re(H<sub>2</sub>O)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup>, yielding a suspension that was heated and finally\ncentrifuged. The formation of the rhenium complex <bold>8</bold> was\nevidenced by the ESI-MS of the clear water solution, which gave a\nunique signal with the isotopic pattern of rhenium. This peak corresponds\nto the molecular signal (M + Na<sup>+</sup>) previously observed for\ncomplex <bold>8</bold>. It should be emphasized that this reaction\nruns in aqueous medium, even though the solubility of the reactants\nin water is very low (the solubility of the zinc complex <bold>4</bold> was measured by inductively coupled plasma optical emission spectrometry\n(ICP-OES); it was as low as 0.66 ppm). Consequently, this approach\nprovides a simple method for performing high-yield reactions with\na low concentration of the reactants in the reaction medium. The application\nof this method to radiopharmacy could provide radiopharmaceuticals\nwith a very high ratio of labeled to unlabeled biomolecules (see Figure ).\n</p>", "clean_text": "Although the reaction between the zinc dithiocarbamates 3-6 and the rhenium carbonyl [ReBr3(CO)3]2- confirms the viability of the transmetalation reaction, to take advantage of this approach in radiopharmacy, the reaction must be feasible in aqueous medium. With the aim of exploring this possibility, the reaction of an aqueous solution of [Re(H2O)3(CO)3]+ at a very low concentration (10 ppm) with the zinc complex 4 was studied as shown in Scheme . Complex 4 and triphenylphosphine were successively added as solid compounds to an aqueous solution of [Re(H2O)3(CO)3]+, yielding a suspension that was heated and finally centrifuged. The formation of the rhenium complex 8 was evidenced by the ESI-MS of the clear water solution, which gave a unique signal with the isotopic pattern of rhenium. This peak corresponds to the molecular signal (M + Na+) previously observed for complex 8. It should be emphasized that this reaction runs in aqueous medium, even though the solubility of the reactants in water is very low (the solubility of the zinc complex 4 was measured by inductively coupled plasma optical emission spectrometry (ICP-OES); it was as low as 0.66 ppm). Consequently, this approach provides a simple method for performing high-yield reactions with a low concentration of the reactants in the reaction medium. The application of this method to radiopharmacy could provide radiopharmaceuticals with a very high ratio of labeled to unlabeled biomolecules (see Figure ). ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 38, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0011.tif\"></graphic>\n</fig>", "clean_text": " 7  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 39, "type": "text", "classification": ["else"], "content": "<title>Conclusions</title><p>The zinc dithiocarbamate of isonipecotic\nacid (<bold>1</bold>) and its succinimidyl ester (<bold>2</bold>)\nare new complexes that have been synthesized using simple preparation\nprocedures which allow obtaining the desired complex in high yield\nand purity for use in subsequent reactions. The X-ray diffraction\nanalyses of these complexes have shown very similar dinuclear structures\nfor both, confirming that there are no relevant interactions between\nthe succinimidyl fragment and the metal atom in <bold>2</bold>. All\nthese results indicate that compound <bold>2</bold> can be an excellent\nstarting material for the conjugation of biomolecules to zinc. Hence,\nwe established the versatility of complex <bold>2</bold> to act as\na synthon for linking the zinc dithiocarbamate fragment to molecules\nthat contain a primary or secondary amine by a coupling reaction with\nthe succinimidyl ester group. This reaction has been performed with\nglycine, \u03b2-alanine, 1-(2-methoxyphenyl)piperazine, and <sc>d</sc>-(+)-glucosamine, yielding the zinc complexes <bold>3</bold>\u2013<bold>6</bold>. The low solubility of these complexes, in conjunction with\nthe high yield of the coupling reaction, permits obtaining pure <bold>3</bold>\u2013<bold>6</bold> by simple addition of an alcohol or\nalcohol/water mixture to the reaction medium.</p>", "clean_text": "Conclusions\n\nThe zinc dithiocarbamate of isonipecotic acid (1) and its succinimidyl ester (2) are new complexes that have been synthesized using simple preparation procedures which allow obtaining the desired complex in high yield and purity for use in subsequent reactions. The X-ray diffraction analyses of these complexes have shown very similar dinuclear structures for both, confirming that there are no relevant interactions between the succinimidyl fragment and the metal atom in 2. All these results indicate that compound 2 can be an excellent starting material for the conjugation of biomolecules to zinc. Hence, we established the versatility of complex 2 to act as a synthon for linking the zinc dithiocarbamate fragment to molecules that contain a primary or secondary amine by a coupling reaction with the succinimidyl ester group. This reaction has been performed with glycine, \u03b2-alanine, 1-(2-methoxyphenyl)piperazine, and d-(+)-glucosamine, yielding the zinc complexes 3-6. The low solubility of these complexes, in conjunction with the high yield of the coupling reaction, permits obtaining pure 3-6 by simple addition of an alcohol or alcohol/water mixture to the reaction medium.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 40, "type": "text", "classification": ["else"], "content": "<p>The study of the\ntransmetalation reaction between the rhenium carbonyl [ReBr<sub>3</sub>(CO)<sub>3</sub>]<sup>2\u2013</sup> and the zinc dithiocarbamates <bold>3</bold>\u2013<bold>6</bold> has led to the rhenium dithiocarbamates <bold>7</bold>\u2013<bold>10</bold>, in accord with the higher stability\nof complexes with an element of the third transition series with a\nd<sup>6</sup> configuration with respect to the zinc (d<sup>10</sup>). The crystal structure analysis of <bold>8</bold> was solved, showing\na coordination set around the rhenium metal similar to that of other\n[Re(CO)<sub>3</sub>(SS)(P)] complexes. The study of the transmetalation\nbetween a very dilute solution of [Re(H<sub>2</sub>O)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup> (10 ppm) and complex <bold>4</bold> has evidenced\nthat this reaction is so favorable that it takes place at very low\nmetal concentration, although the water solubility of the zinc complex <bold>4</bold> is as low as 0.66 ppm. This result highlights the potential\napplication of this approach to the preparation of radiopharmaceuticals,\nsince it can improve the ratio of labeled to unlabeled biomolecules\nbecause the concentration of the zinc labeling reagent in the reaction\nmedia is limited by its low solubility. If it is true that the radionuclide\nconcentration under labeling conditions is still below the solubility\nof <bold>4</bold>, it should be noted that complex <bold>4</bold> is\njust a model compound (\u03b2-alanine methyl ester derivative) and\nit is reasonable to think that zinc complexes bioconjugated to larger\nbiomolecules may show lower solubility.</p>", "clean_text": "The study of the transmetalation reaction between the rhenium carbonyl [ReBr3(CO)3]2- and the zinc dithiocarbamates 3-6 has led to the rhenium dithiocarbamates 7-10, in accord with the higher stability of complexes with an element of the third transition series with a d6 configuration with respect to the zinc (d10). The crystal structure analysis of 8 was solved, showing a coordination set around the rhenium metal similar to that of other [Re(CO)3(SS)(P)] complexes. The study of the transmetalation between a very dilute solution of [Re(H2O)3(CO)3]+ (10 ppm) and complex 4 has evidenced that this reaction is so favorable that it takes place at very low metal concentration, although the water solubility of the zinc complex 4 is as low as 0.66 ppm. This result highlights the potential application of this approach to the preparation of radiopharmaceuticals, since it can improve the ratio of labeled to unlabeled biomolecules because the concentration of the zinc labeling reagent in the reaction media is limited by its low solubility. If it is true that the radionuclide concentration under labeling conditions is still below the solubility of 4, it should be noted that complex 4 is just a model compound (\u03b2-alanine methyl ester derivative) and it is reasonable to think that zinc complexes bioconjugated to larger biomolecules may show lower solubility.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 41, "type": "text", "classification": ["else"], "content": "<title>Experimental Section</title><p>All reactions were performed under\nnitrogen using standard Schlenk tube techniques. Infrared spectra\nwere recorded with a Perkin-Elmer 2000 FT spectrometer. The NMR spectra\nwere recorded in the <italic toggle=\"yes\">Servei de Ressona\u0300ncia Magne\u0300tica\nNuclear de la Universitat Auto\u0300noma de Barcelona</italic> on\nBruker DPX-250, DPX-360, and AV400 instruments. Microanalyses were\nperformed by the <italic toggle=\"yes\">Servei d\u2019Ana\u0300lisi Qu\u0131\u0301mica\ndel Departament de Qu\u0131\u0301mica de la Universitat Auto\u0300noma\nde Barcelona</italic>. Mass spectra and exact mass measurements were\nrespectively obtained on an Esquire 3000 with electrospray ionization\nand a Bruker Daltonics ion trap and on a Bruker Apollo microTOFQ with\nelectrospray ionization by the <italic toggle=\"yes\">Servei d\u2019Ana\u0300lisi\nQu\u0131\u0301mica del Departament de Qu\u0131\u0301mica de la\nUniversitat Auto\u0300noma de Barcelona</italic>. The zinc concentration\nin water solutions was measured by inductively coupled plasma optical\nemission spectrometry (ICP-OES) on a Polyscan 61E (Thermo Jarrell\nAsh) spectrometer by <italic toggle=\"yes\">Servei d\u2019Ana\u0300lisi Qu\u0131\u0301mica\ndel Departament de Qu\u0131\u0301mica de la Universitat Auto\u0300noma\nde Barcelona</italic>.</p>", "clean_text": "Experimental Section\n\nAll reactions were performed under nitrogen using standard Schlenk tube techniques. Infrared spectra were recorded with a Perkin-Elmer 2000 FT spectrometer. The NMR spectra were recorded in the Servei de Ressona\u0300ncia Magne\u0300tica Nuclear de la Universitat Auto\u0300noma de Barcelona on Bruker DPX-250, DPX-360, and AV400 instruments. Microanalyses were performed by the Servei d'Ana\u0300lisi Qu\u0131\u0301mica del Departament de Qu\u0131\u0301mica de la Universitat Auto\u0300noma de Barcelona. Mass spectra and exact mass measurements were respectively obtained on an Esquire 3000 with electrospray ionization and a Bruker Daltonics ion trap and on a Bruker Apollo microTOFQ with electrospray ionization by the Servei d'Ana\u0300lisi Qu\u0131\u0301mica del Departament de Qu\u0131\u0301mica de la Universitat Auto\u0300noma de Barcelona. The zinc concentration in water solutions was measured by inductively coupled plasma optical emission spectrometry (ICP-OES) on a Polyscan 61E (Thermo Jarrell Ash) spectrometer by Servei d'Ana\u0300lisi Qu\u0131\u0301mica del Departament de Qu\u0131\u0301mica de la Universitat Auto\u0300noma de Barcelona.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 42, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Complex <bold>1</bold>\n</title><p>A solution of NaOH\n(2.8 g, 70 mmol) in water (70 mL) was added to a solution of isonipecotic\nacid (4.5 g, 35 mmol) in methanol (MeOH, 140 mL), and the resulting\nsolution was cooled to 0 \u00b0C. Carbon disulfide (2.45 mL, 40.9\nmmol) was slowly added to this cold solution, and the mixture was\nstirred at this temperature for 1 h. Next, the cooling bath was removed\nand the mixture was stirred overnight at room temperature. After this\ntime, a solution of zinc acetate (3.8 g, 17.5 mmol) in water (35 mL)\nwas added dropwise with vigorous stirring to the previous mixture\nfor a period of 4 h. The resulting solution was cooled to 4 \u00b0C,\nand colorless crystals precipitated after 12\u201324 h. This solid\nwas filtered off, washed with MeOH and Et<sub>2</sub>O, and dried\nunder vacuum, giving a white powder (8.1 g, 84% yield). IR (KBr, cm<sup>\u20131</sup>): 1553 (COO<sup>\u2013</sup>), 1493 (CN, S<sub>2</sub>CN). <sup>1</sup>H NMR (D<sub>2</sub>O, \u03b4 in ppm): 4.97\n(d, <italic toggle=\"yes\">J</italic> = 12.9 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.32 (dt, <italic toggle=\"yes\">J</italic> = 12.7 Hz, <italic toggle=\"yes\">J</italic> = 2.7 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.30 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.95 (dd, <italic toggle=\"yes\">J</italic> = 13.7 Hz, <italic toggle=\"yes\">J</italic> = 3.3 Hz, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.65 (dq, <italic toggle=\"yes\">J</italic> = 13.2 Hz, <italic toggle=\"yes\">J</italic> =  3.7 Hz, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (D<sub>2</sub>O, \u03b4 in ppm):\n201.8 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 184.1 (<italic toggle=\"yes\">C</italic>OO<sup>\u2013</sup>), 52.5 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 43.8 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 29,4 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (negative mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 493 (M \u2013 Na<sup>+</sup>). Anal. Calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>Na<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Zn\u00b72H<sub>2</sub>O: C, 30.35; H, 4.00; N, 5.06. Found:\nC, 30.39; H, 3.91; N, 4.97.</p>", "clean_text": "Synthesis of Complex 1 \n\nA solution of NaOH (2.8 g, 70 mmol) in water (70 mL) was added to a solution of isonipecotic acid (4.5 g, 35 mmol) in methanol (MeOH, 140 mL), and the resulting solution was cooled to 0 \u00b0C. Carbon disulfide (2.45 mL, 40.9 mmol) was slowly added to this cold solution, and the mixture was stirred at this temperature for 1 h. Next, the cooling bath was removed and the mixture was stirred overnight at room temperature. After this time, a solution of zinc acetate (3.8 g, 17.5 mmol) in water (35 mL) was added dropwise with vigorous stirring to the previous mixture for a period of 4 h. The resulting solution was cooled to 4 \u00b0C, and colorless crystals precipitated after 12-24 h. This solid was filtered off, washed with MeOH and Et2O, and dried under vacuum, giving a white powder (8.1 g, 84% yield). IR (KBr, cm-1): 1553 (COO-), 1493 (CN, S2CN). 1H NMR (D2O, \u03b4 in ppm): 4.97 (d, J = 12.9 Hz, 2H, S2CNCH 2,eq), 3.32 (dt, J = 12.7 Hz, J = 2.7 Hz, 2H, S2CNCH 2,ax), 2.30 (m, 1H, S2CNCH2CH2CH), 1.95 (dd, J = 13.7 Hz, J = 3.3 Hz, 2H, S2CNCH2CH 2,eq), 1.65 (dq, J = 13.2 Hz, J =  3.7 Hz, 2H, S2CNCH2CH 2,ax). 13C NMR (D2O, \u03b4 in ppm): 201.8 (S2 CN), 184.1 (COO-), 52.5 (S2CNCH2), 43.8 (S2CNCH2CH2 CH), 29,4 (S2CNCH2 CH2). ESI MS (negative mode, m/z): 493 (M - Na+). Anal. Calcd for C14H18N2Na2O4S4Zn\u22c52H2O: C, 30.35; H, 4.00; N, 5.06. Found: C, 30.39; H, 3.91; N, 4.97.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 43, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Complex <bold>2</bold>\n</title><p>\n<italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>\u2032,<italic toggle=\"yes\">N</italic>\u2032-Tetramethyl-<italic toggle=\"yes\">O</italic>-(<italic toggle=\"yes\">N</italic>-succinimidyl)uronium\ntetrafluoroborate (TSTU; 256 mg, 0.85 mmol) was added to a solution\nof complex <bold>1</bold> (200 mg, 0.36 mmol) and <italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>-diisopropylethylamine (DIPEA; 13 \u03bcL, 0.07\nmmol) in dry dimethylformamide (DMF; 1 mL). The heterogeneous mixture\nwas stirred for 16 h, and then 140 mL of a H<sub>2</sub>O/EtOH mixture\n(1/1, v/v) was added. The crude precipitate was centrifuged and washed\nwith EtOH and Et<sub>2</sub>O to give a white solid (239 mg, 99% yield)\nthat can be recrystallized from hot acetonitrile. IR (KBr, cm<sup>\u20131</sup>): 1736 (C\ue5fbO, succinimidyl), 1634 (C\ue5fbO,\nester), 1493 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 4.73 (d, <italic toggle=\"yes\">J</italic> =  13.4 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.53 (t, <italic toggle=\"yes\">J</italic> =  12.4 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 3.22 (m, 1; H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 2.83 (s, 4H, succinimidyl),\n2.10 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.70 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 203.4 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N),\n170.1 (<italic toggle=\"yes\">C</italic>O, succinimidyl), 169.8 (<italic toggle=\"yes\">C</italic>O, ester), 49.9 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>),\n36.3 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 27.4 (<italic toggle=\"yes\">C</italic>H<sub>2</sub>, succinimidyl), 25.5 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive\nmode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 688.9 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>22</sub>H<sub>26</sub>N<sub>4</sub>O<sub>8</sub>S<sub>4</sub>Zn: C, 39.55; H, 3.92; N, 8.39. Found: C, 39.82;\nH, 3.83; N, 8.61.</p>", "clean_text": "Synthesis of Complex 2 \n\n N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate (TSTU; 256 mg, 0.85 mmol) was added to a solution of complex 1 (200 mg, 0.36 mmol) and N,N-diisopropylethylamine (DIPEA; 13 \u03bcL, 0.07 mmol) in dry dimethylformamide (DMF; 1 mL). The heterogeneous mixture was stirred for 16 h, and then 140 mL of a H2O/EtOH mixture (1/1, v/v) was added. The crude precipitate was centrifuged and washed with EtOH and Et2O to give a white solid (239 mg, 99% yield) that can be recrystallized from hot acetonitrile. IR (KBr, cm-1): 1736 (C\ue5fbO, succinimidyl), 1634 (C\ue5fbO, ester), 1493 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 4.73 (d, J =  13.4 Hz, 2H, S2CNCH 2,eq), 3.53 (t, J =  12.4 Hz, 2H, S2CNCH 2,ax), 3.22 (m, 1; H, S2CNCH2CH2CH), 2.83 (s, 4H, succinimidyl), 2.10 (m, 2H, S2CNCH2CH 2,eq), 1.70 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 203.4 (S2 CN), 170.1 (CO, succinimidyl), 169.8 (CO, ester), 49.9 (S2CNCH2), 36.3 (S2CNCH2CH2 CH), 27.4 (CH2, succinimidyl), 25.5 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 688.9 (M + Na+). Anal. Calcd for C22H26N4O8S4Zn: C, 39.55; H, 3.92; N, 8.39. Found: C, 39.82; H, 3.83; N, 8.61.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 44, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Complexes <bold>3</bold>\u2013<bold>5</bold>\n</title><p>Complex <bold>2</bold> (1.0 g, 1.5 mmol) was dissolved in dry DMF\n(10 mL). The appropriate amine (3.8 mmol) and DIPEA (7.5 mmol) was\nadded to the solution, and the reaction mixture was stirred overnight.\nA mixture of water and EtOH (1/1, v/v) (100 mL) was added, and the\ncrude product was centrifuged and washed with the same mixture to\neliminate the excess of the amine and DIPEA. The product was dried\nunder vacuum.</p>", "clean_text": "Synthesis of Complexes 3-5 \n\nComplex 2 (1.0 g, 1.5 mmol) was dissolved in dry DMF (10 mL). The appropriate amine (3.8 mmol) and DIPEA (7.5 mmol) was added to the solution, and the reaction mixture was stirred overnight. A mixture of water and EtOH (1/1, v/v) (100 mL) was added, and the crude product was centrifuged and washed with the same mixture to eliminate the excess of the amine and DIPEA. The product was dried under vacuum.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 45, "type": "text", "classification": ["synthesis condition", "property"], "content": "<title>Complex <bold>3</bold>\n</title><p>Yield: 678 mg, 74%. IR (KBr,\ncm<sup>\u20131</sup>): 3294 (N\u2013H, amide), 1753 (C\ue5fbO,\namide), 1646 (C\ue5fbO, ester), 1492 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm):\n8.4 (t, <italic toggle=\"yes\">J</italic> = 5.96 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 4.8\n(d, <italic toggle=\"yes\">J</italic> = 12.86 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.8 (d, <italic toggle=\"yes\">J</italic> = 5.96 Hz, 2H, NC<italic toggle=\"yes\">H</italic>\n<sub>\n<italic toggle=\"yes\">2</italic>\n</sub>CO), 3.62 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>\n<italic toggle=\"yes\">3</italic>\n</sub>), 3.31 (m, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.53 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.82 (m, 2H,\nS<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>),\n1.58 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 202.7 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 174.6\n(<italic toggle=\"yes\">C</italic>O, amide), 170.6 (NCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>O), 51.7 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 50.6 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 39.9 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.2 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 637.0 (M + Na<sup>+</sup>). Anal. Calcd for\nC<sub>20</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S<sub>4</sub>Zn: C, 38.99; H, 4.91; N, 9.09. Found: C, 38.71; H, 4.91; N, 8.92.</p>", "clean_text": "Complex 3 \n\nYield: 678 mg, 74%. IR (KBr, cm-1): 3294 (N-H, amide), 1753 (C\ue5fbO, amide), 1646 (C\ue5fbO, ester), 1492 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 8.4 (t, J = 5.96 Hz, 1H, NH), 4.8 (d, J = 12.86 Hz, 2H, S2CNCH 2,eq), 3.8 (d, J = 5.96 Hz, 2H, NCH  2 CO), 3.62 (s, 3H, OCH  3 ), 3.31 (m, 2H, S2CNCH 2,ax), 2.53 (m, 1H, S2CNCH2CH2CH), 1.82 (m, 2H, S2CNCH2CH 2,eq), 1.58 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 202.7 (S2 CN), 174.6 (CO, amide), 170.6 (NCH2 CO), 51.7 (OCH3), 50.6 (S2CNCH2), 39.9 (S2CNCH2CH2 CH), 28.2 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 637.0 (M + Na+). Anal. Calcd for C20H30N4O6S4Zn: C, 38.99; H, 4.91; N, 9.09. Found: C, 38.71; H, 4.91; N, 8.92.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition', 'property']"}}, {"idx": 46, "type": "text", "classification": ["property"], "content": "<title>Complex <bold>4</bold>\n</title><p>Yield: 580 mg, 58%. IR (KBr,\ncm<sup>\u20131</sup>): 3271 (N\u2013H, amide), 1746 (C\ue5fbO,\namide), 1640 (C\ue5fbO, ester), 1492 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm):\n8.0 (t, <italic toggle=\"yes\">J</italic> = 5.41 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 4.8\n(d, <italic toggle=\"yes\">J</italic> = 12.6 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.60 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>3</sub>),\n3.27 (m, 4H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>ax</sub>, NCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CO), 2.45 (m, 3H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>, NC<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CH<sub>2</sub>CO), 1.76 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.57 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 202.7\n(S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 174.0 (<italic toggle=\"yes\">C</italic>O, amide),\n172.2 (NHCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>O), 51.8 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 51.1 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 40.6 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 35.1 (NHCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>CO), 34.0 (NH<italic toggle=\"yes\">C</italic>H<sub>2</sub>CH<sub>2</sub>CO), 28.7 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>):\n665.1 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>22</sub>H<sub>34</sub>N<sub>4</sub>O<sub>6</sub>S<sub>4</sub>Zn\u00b7H<sub>2</sub>O: C,\n39.90;; H, 5.48; N, 8.46. Found: C, 39.96; H, 5.37; N, 8.41.</p>", "clean_text": "Complex 4 \n\nYield: 580 mg, 58%. IR (KBr, cm-1): 3271 (N-H, amide), 1746 (C\ue5fbO, amide), 1640 (C\ue5fbO, ester), 1492 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 8.0 (t, J = 5.41 Hz, 1H, NH), 4.8 (d, J = 12.6 Hz, 2H, S2CNCH 2,eq), 3.60 (s, 3H, OCH 3), 3.27 (m, 4H, S2CNCH ax, NCH2CH 2CO), 2.45 (m, 3H, S2CNCH2CH2CH, NCH 2CH2CO), 1.76 (m, 2H, S2CNCH2CH 2,eq), 1.57 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 202.7 (S2 CN), 174.0 (CO, amide), 172.2 (NHCH2CH2 CO), 51.8 (OCH3), 51.1 (S2CNCH2), 40.6 (S2CNCH2CH2 CH), 35.1 (NHCH2 CH2CO), 34.0 (NHCH2CH2CO), 28.7 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 665.1 (M + Na+). Anal. Calcd for C22H34N4O6S4Zn\u22c5H2O: C, 39.90;; H, 5.48; N, 8.46. Found: C, 39.96; H, 5.37; N, 8.41.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 47, "type": "text", "classification": ["property"], "content": "<title>Complex <bold>5</bold>\n</title><p>Yield: 870 mg, 71%. IR (KBr,\ncm<sup>\u20131</sup>): 1639 (C\ue5fbO, amide), 1436 (C\u2013N,\nS<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 6.96\u20136.89 (m, 4H, ArH), 4.87 (d, <italic toggle=\"yes\">J</italic> =  12.26 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.79 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>\n<italic toggle=\"yes\">3</italic>\n</sub>), 3.68 (s, 2 H, piperazine ring), 3.60 (s, 2H, piperazine\nring), 3.40 (m, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 3.05 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 2.97 (s, 2H, piperazine ring), 2.90 (s, 2H, piperazine\nring), 1.80 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.59 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 202.6 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 172.0 (<italic toggle=\"yes\">C</italic>O, amide), 152.0\u2013111.9 (ArH),\n55.4 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 50.8 (piperazine ring), 50.6\n(S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 50.2 (piperazine\nring), 45.2 (piperazine ring), 41.4 (piperazine ring), 35.6 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.3 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive\nmode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 843.4 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>36</sub>H<sub>48</sub>N<sub>6</sub>O<sub>4</sub>S<sub>4</sub>Zn: C, 52.57; H, 5.88; N, 10.22. Found: C, 52.24;\nH, 5.82; N, 9.86.</p>", "clean_text": "Complex 5 \n\nYield: 870 mg, 71%. IR (KBr, cm-1): 1639 (C\ue5fbO, amide), 1436 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 6.96-6.89 (m, 4H, ArH), 4.87 (d, J =  12.26 Hz, 2H, S2CNCH 2,eq), 3.79 (s, 3H, OCH  3 ), 3.68 (s, 2 H, piperazine ring), 3.60 (s, 2H, piperazine ring), 3.40 (m, 2H, S2CNCH 2,ax), 3.05 (m, 1H, S2CNCH2CH2CH), 2.97 (s, 2H, piperazine ring), 2.90 (s, 2H, piperazine ring), 1.80 (m, 2H, S2CNCH2CH 2,eq), 1.59 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 202.6 (S2 CN), 172.0 (CO, amide), 152.0-111.9 (ArH), 55.4 (OCH3), 50.8 (piperazine ring), 50.6 (S2CNCH2), 50.2 (piperazine ring), 45.2 (piperazine ring), 41.4 (piperazine ring), 35.6 (S2CNCH2CH2 CH), 28.3 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 843.4 (M + Na+). Anal. Calcd for C36H48N6O4S4Zn: C, 52.57; H, 5.88; N, 10.22. Found: C, 52.24; H, 5.82; N, 9.86.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 48, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Complex <bold>6</bold>\n</title><p>The complex <bold>2</bold> (1.0 g, 1.5 mmol) was dissolved in dry DMF (10 mL). Glucosamine\nchlorhydrate (3.8 mmol) and DIPEA (3.8 mmol) was added to the solution,\nwhich was then stirred for 3 h. Methanol (100 mL) was added, and the\ncrude mixture was centrifuged and washed with the same solvent to\neliminate the excess glucosamine and DIPEA. The product was dried\nunder vacuum (550 mg, 44% yield). IR (KBr, cm<sup>\u20131</sup>):\n3411 (O\u2013H, alcohols), 1644 (C\ue5fbO, amide), 1492 (C\u2013N,\nS<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 7.69 (d, <italic toggle=\"yes\">J</italic> = 8.31 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 7.64 (d, J = 7.65 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 6.47\n(d, <italic toggle=\"yes\">J</italic> = 6.34 Hz, 1H, NHCHC<italic toggle=\"yes\">H</italic>O), 6.41\n(d, <italic toggle=\"yes\">J</italic> = 4.28 Hz, 1H, NHCHC<italic toggle=\"yes\">H</italic>O), 4.90\u20134.30\n(m, 6 H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>, glucosamine\nring), 3.60\u20133.40 (m, 5H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>, glucosamine ring), 3.31\u20133.00 (m, 2H, glucosamine\nring), 2.56 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.71 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.60 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-d<sub>6</sub>, \u03b4 in ppm, except glucosamine ring resonances): 192.5 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 163.8 (<italic toggle=\"yes\">C</italic>O, amide),\n51.2 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 40.8 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.5 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive\nmode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 817.2 (M + Na<sup>+</sup>); Anal. Calcd for C<sub>26</sub>H<sub>42</sub>N<sub>4</sub>O<sub>12</sub>S<sub>4</sub>Zn\u00b72H<sub>2</sub>O: C, 37.52; H, 5.57;\nN, 6.73. Found: C, 37.88; H, 5.42; N, 6.69.</p>", "clean_text": "Synthesis of Complex 6 \n\nThe complex 2 (1.0 g, 1.5 mmol) was dissolved in dry DMF (10 mL). Glucosamine chlorhydrate (3.8 mmol) and DIPEA (3.8 mmol) was added to the solution, which was then stirred for 3 h. Methanol (100 mL) was added, and the crude mixture was centrifuged and washed with the same solvent to eliminate the excess glucosamine and DIPEA. The product was dried under vacuum (550 mg, 44% yield). IR (KBr, cm-1): 3411 (O-H, alcohols), 1644 (C\ue5fbO, amide), 1492 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 7.69 (d, J = 8.31 Hz, 1H, NH), 7.64 (d, J = 7.65 Hz, 1H, NH), 6.47 (d, J = 6.34 Hz, 1H, NHCHCHO), 6.41 (d, J = 4.28 Hz, 1H, NHCHCHO), 4.90-4.30 (m, 6 H, S2CNCH 2,eq, glucosamine ring), 3.60-3.40 (m, 5H, S2CNCH 2,ax, glucosamine ring), 3.31-3.00 (m, 2H, glucosamine ring), 2.56 (m, 1H, S2CNCH2CH2CH), 1.71 (m, 2H, S2CNCH2CH 2,eq), 1.60 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d6, \u03b4 in ppm, except glucosamine ring resonances): 192.5 (S2 CN), 163.8 (CO, amide), 51.2 (S2CNCH2), 40.8 (S2CNCH2CH2 CH), 28.5 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 817.2 (M + Na+); Anal. Calcd for C26H42N4O12S4Zn\u22c52H2O: C, 37.52; H, 5.57; N, 6.73. Found: C, 37.88; H, 5.42; N, 6.69.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 49, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Complexes <bold>7</bold>\u2013<bold>10</bold>\n</title><p>The precursor [NEt<sub>4</sub>]<sub>2</sub>[Re(CO)<sub>3</sub>Br<sub>3</sub>] (100 mg, 0.14 mmol) was dissolved in MeOH\n(10 mL) and added to a suspension of <bold>3</bold>\u2013<bold>6</bold> (0.08 mmol) in the same solvent (30 mL). The mixture was heated\nto reflux for 1 h. Next, triphenylphosphine (34 mg, 0.14 mmol) was\nadded and the resulting suspension was heated to reflux for an additional\n1 h. The clear solution that was obtained was concentrated under vacuum\nto 5 mL, and the resulting solution was cooled to 4 \u00b0C to crystallize\nthe complex. The complex was washed with cold MeOH and Et<sub>2</sub>O to give a white solid.</p>", "clean_text": "Synthesis of Complexes 7-10 \n\nThe precursor [NEt4]2[Re(CO)3Br3] (100 mg, 0.14 mmol) was dissolved in MeOH (10 mL) and added to a suspension of 3-6 (0.08 mmol) in the same solvent (30 mL). The mixture was heated to reflux for 1 h. Next, triphenylphosphine (34 mg, 0.14 mmol) was added and the resulting suspension was heated to reflux for an additional 1 h. The clear solution that was obtained was concentrated under vacuum to 5 mL, and the resulting solution was cooled to 4 \u00b0C to crystallize the complex. The complex was washed with cold MeOH and Et2O to give a white solid.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 50, "type": "text", "classification": ["property"], "content": "<title>Complex <bold>7</bold>\n</title><p>Yield: 58 mg, 51%. IR (KBr,\ncm<sup>\u20131</sup>): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723\n(C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (CDCl<sub>3</sub>, \u03b4 in ppm):\n7.53\u20137.28 (m, 15 H, ArH), 5.92 (t, <italic toggle=\"yes\">J</italic> = 5.07\nHz, 1H, N<italic toggle=\"yes\">H</italic>), 4.31 (d, <italic toggle=\"yes\">J</italic> = 13.81\nHz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), also observed\n4.21 (d, <italic toggle=\"yes\">J</italic> = 13.81 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 4.05 (d, <italic toggle=\"yes\">J</italic> = 5.07 Hz,\n2H, NC<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CO), 3.81 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>3</sub>), 2.74 (t, <italic toggle=\"yes\">J</italic> = 11.96 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), also observed 2.50\n(t, <italic toggle=\"yes\">J</italic> = 11.96 Hz, 2 H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.28 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.67 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.30 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, \u03b4 in ppm, except phenyl resonances): 210.1 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 193.2\u2013190.4 (carbonyls), 173.7\n(amide), 170.5 (ester), 51.6 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 43.4\n(S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>\n<italic toggle=\"yes\">2</italic>\n</sub>CH<sub>2</sub>CH), 41.3 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 40.4 (N<italic toggle=\"yes\">C</italic>H<sub>2</sub>CO), 26.6 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>CH). <sup>31</sup>P NMR (CDCl<sub>3</sub>, \u03b4 in ppm): 14.8, also observed 14.4.\nESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 831.0\n(M + Na<sup>+</sup>); Anal. Calcd for C<sub>31</sub>H<sub>30</sub>N<sub>2</sub>O<sub>6</sub>PReS<sub>2</sub>\u00b7H<sub>2</sub>O: C,\n45.08; H, 3.91; N, 3.39. Found: C, 45.24; H, 4.08; N, 3.53.</p>", "clean_text": "Complex 7 \n\nYield: 58 mg, 51%. IR (KBr, cm-1): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723 (C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C-N, S2CN). 1H NMR (CDCl3, \u03b4 in ppm): 7.53-7.28 (m, 15 H, ArH), 5.92 (t, J = 5.07 Hz, 1H, NH), 4.31 (d, J = 13.81 Hz, 2H, S2CNCH 2,eq), also observed 4.21 (d, J = 13.81 Hz, 2H, S2CNCH 2,eq), 4.05 (d, J = 5.07 Hz, 2H, NCH 2CO), 3.81 (s, 3H, OCH 3), 2.74 (t, J = 11.96 Hz, 2H, S2CNCH 2,ax), also observed 2.50 (t, J = 11.96 Hz, 2 H, S2CNCH 2,ax), 2.28 (m, 1H, S2CNCH2CH2CH), 1.67 (m, 2H, S2CNCH2CH 2,eq), 1.30 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (CDCl3, \u03b4 in ppm, except phenyl resonances): 210.1 (S2 CN), 193.2-190.4 (carbonyls), 173.7 (amide), 170.5 (ester), 51.6 (OCH3), 43.4 (S2CNCH 2 CH2CH), 41.3 (S2CNCH2CH2 CH), 40.4 (NCH2CO), 26.6 (S2CNCH2 CH2CH). 31P NMR (CDCl3, \u03b4 in ppm): 14.8, also observed 14.4. ESI MS (positive mode, m/z): 831.0 (M + Na+); Anal. Calcd for C31H30N2O6PReS2\u22c5H2O: C, 45.08; H, 3.91; N, 3.39. Found: C, 45.24; H, 4.08; N, 3.53.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 51, "type": "text", "classification": ["property"], "content": "<title>Complex <bold>8</bold>\n</title><p>Yield: 45 mg, 40%. IR (KBr,\ncm<sup>\u20131</sup>): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723\n(C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (CDCl<sub>3</sub>, \u03b4 in ppm):\n7.53\u20137.28 (m, 15 H, ArH), 6.10 (m, 1H, N<italic toggle=\"yes\">H</italic>),\n4.31 (d, <italic toggle=\"yes\">J</italic> =  13.54 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), also observed 4.21 (d, <italic toggle=\"yes\">J</italic> =  13.54 Hz, 2 H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.71 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>3</sub>), 3.55 (q, <italic toggle=\"yes\">J</italic> =  5.81 Hz, 2H, NC<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CH<sub>2</sub>CO), 2.70 (t, <italic toggle=\"yes\">J</italic> =  13.54 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), also observed 2.40 (t, <italic toggle=\"yes\">J</italic> =  13.54 Hz, 2 H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.56 (q, <italic toggle=\"yes\">J</italic> =  5.81 Hz, 2H, NCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CO), 2.17 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.68 (m, 2H,\nS<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>),\n1.26 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, \u03b4 in ppm,\nexcept phenyl resonances): 210.9 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N),\n193.2\u2013190.4 (carbonyls), 174.2 (amide), 44.5 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>\n<italic toggle=\"yes\">2</italic>\n</sub>), 34.9 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 33.8 (N<italic toggle=\"yes\">C</italic>H<sub>2</sub>CH<sub>2</sub>CO), 33.7 (NCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>CO),\n29.8 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 27.6 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). <sup>31</sup>P NMR (CDCl<sub>3</sub>, \u03b4 in ppm): 15.3, also\nobserved 14.7. ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 845.0 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>32</sub>H<sub>32</sub>N<sub>2</sub>O<sub>6</sub>PReS<sub>2</sub>: C, 46.76; H,\n3.92; N, 3.41. Found: C, 46.68; H, 4.00; N, 3.34.</p>", "clean_text": "Complex 8 \n\nYield: 45 mg, 40%. IR (KBr, cm-1): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723 (C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C-N, S2CN). 1H NMR (CDCl3, \u03b4 in ppm): 7.53-7.28 (m, 15 H, ArH), 6.10 (m, 1H, NH), 4.31 (d, J =  13.54 Hz, 2H, S2CNCH 2,eq), also observed 4.21 (d, J =  13.54 Hz, 2 H, S2CNCH 2,eq), 3.71 (s, 3H, OCH 3), 3.55 (q, J =  5.81 Hz, 2H, NCH 2CH2CO), 2.70 (t, J =  13.54 Hz, 2H, S2CNCH 2,ax), also observed 2.40 (t, J =  13.54 Hz, 2 H, S2CNCH 2,ax), 2.56 (q, J =  5.81 Hz, 2H, NCH2CH 2CO), 2.17 (m, 1H, S2CNCH2CH2CH), 1.68 (m, 2H, S2CNCH2CH 2,eq), 1.26 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (CDCl3, \u03b4 in ppm, except phenyl resonances): 210.9 (S2 CN), 193.2-190.4 (carbonyls), 174.2 (amide), 44.5 (S2CNCH 2 ), 34.9 (OCH3), 33.8 (NCH2CH2CO), 33.7 (NCH2 CH2CO), 29.8 (S2CNCH2CH2 CH), 27.6 (S2CNCH2 CH2). 31P NMR (CDCl3, \u03b4 in ppm): 15.3, also observed 14.7. ESI MS (positive mode, m/z): 845.0 (M + Na+). Anal. Calcd for C32H32N2O6PReS2: C, 46.76; H, 3.92; N, 3.41. Found: C, 46.68; H, 4.00; N, 3.34.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 52, "type": "text", "classification": ["property"], "content": "<title>Complex <bold>9</bold>\n</title><p>Yield: 74 mg, 58%. IR (KBr,\ncm<sup>\u20131</sup>): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723\n(C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (CDCl<sub>3</sub>, \u03b4 in ppm):\n7.55\u20136.87 (m, 19H, ArH), 4.31 (d, <italic toggle=\"yes\">J</italic> =  13.05\nHz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), also observed\n4.21 (d, <italic toggle=\"yes\">J</italic> =  13.05 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.88 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>3</sub>), 3.82 s, 2H, piperazine ring), 3.66 (s, 2H, piperazine ring),\n3.10 (s, 4H, piperazine ring), 2.77 (t, <italic toggle=\"yes\">J</italic> =  11.51\nHz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), also observed\n2.53 (t, <italic toggle=\"yes\">J</italic> =  11.51 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.66 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.65 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.44 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, \u03b4 in ppm, except phenyl resonances):\n211.0 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 193.4\u2013190.3 (carbonyls),\n172.2 (amide), 55.6 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 51.4 (piperazine\nring), 44.5 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 37.6\n(S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H),\n27.4 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). <sup>31</sup>P NMR (CDCl<sub>3</sub>, \u03b4 in ppm): 15.3, also\nobserved 14.7. ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 912.0 (M + H<sup>+</sup>). Anal. Calcd for C<sub>39</sub>H<sub>39</sub>N<sub>3</sub>O<sub>4</sub>PReS<sub>2</sub>\u00b7H<sub>2</sub>O: C, 50.42; H, 4.45; N, 4.52. Found: C, 50.55; H, 4.43; N, 4.52.</p>", "clean_text": "Complex 9 \n\nYield: 74 mg, 58%. IR (KBr, cm-1): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723 (C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C-N, S2CN). 1H NMR (CDCl3, \u03b4 in ppm): 7.55-6.87 (m, 19H, ArH), 4.31 (d, J =  13.05 Hz, 2H, S2CNCH 2,eq), also observed 4.21 (d, J =  13.05 Hz, 2H, S2CNCH 2,eq), 3.88 (s, 3H, OCH 3), 3.82 s, 2H, piperazine ring), 3.66 (s, 2H, piperazine ring), 3.10 (s, 4H, piperazine ring), 2.77 (t, J =  11.51 Hz, 2H, S2CNCH 2,ax), also observed 2.53 (t, J =  11.51 Hz, 2H, S2CNCH 2,ax), 2.66 (m, 1H, S2CNCH2CH2CH), 1.65 (m, 2H, S2CNCH2CH 2,eq), 1.44 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (CDCl3, \u03b4 in ppm, except phenyl resonances): 211.0 (S2 CN), 193.4-190.3 (carbonyls), 172.2 (amide), 55.6 (OCH3), 51.4 (piperazine ring), 44.5 (S2CNCH2), 37.6 (S2CNCH2CH2 CH), 27.4 (S2CNCH2 CH2). 31P NMR (CDCl3, \u03b4 in ppm): 15.3, also observed 14.7. ESI MS (positive mode, m/z): 912.0 (M + H+). Anal. Calcd for C39H39N3O4PReS2\u22c5H2O: C, 50.42; H, 4.45; N, 4.52. Found: C, 50.55; H, 4.43; N, 4.52.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 53, "type": "text", "classification": ["property"], "content": "<title>Complex <bold>10</bold>\n</title><p>Yield: 88 mg, 70%. IR (KBr,\ncm<sup>\u20131</sup>): 2006, 1915, 1906, 1892 (C\ue5fcO), 1722\n(C\ue5fbO, amide), 1498 (C\u2013N, S<sub>2</sub>CN) cm<sup>\u20131</sup>. <sup>1</sup>H NMR (acetone-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4\nin ppm): 7.58\u20137.46 (m, 15H, ArH), 6.89 (d, <italic toggle=\"yes\">J</italic> = 8.22 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 6.86 (d, <italic toggle=\"yes\">J</italic> = 8.22 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 5.66 (m, 1H, NHCHC<italic toggle=\"yes\">H</italic>O), 5.62 (m, 1H, NHCHC<italic toggle=\"yes\">H</italic>O), 5.17 (m, 1H, NHC<italic toggle=\"yes\">H</italic>CHO), 5.10 (m, 1H, NHC<italic toggle=\"yes\">H</italic>CHO), 4.31\u20133.33\n(m, 6H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>, glucosamine\nring), 2.83 (alcohols), 2.67 (t, <italic toggle=\"yes\">J</italic> =  11.04 Hz, 2H,\nS<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.55 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.73 (m,\n2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.56 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (acetone-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm, except phenyl resonance): 209.8 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 194.2 (<italic toggle=\"yes\">C</italic>O, amide), 91.4 (NHCH<italic toggle=\"yes\">C</italic>HO), 76.8 (O<italic toggle=\"yes\">C</italic>H(OH)CH<sub>2</sub>OH), 72.2\n(NHCH<italic toggle=\"yes\">C</italic>H(OH)), (NHCHCH(OH)<italic toggle=\"yes\">C</italic>H(OH)),\n61.8 (<italic toggle=\"yes\">C</italic>H<sub>2</sub>OH), 54.7 (NH<italic toggle=\"yes\">C</italic>H), 45.4 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 42.1 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.3 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). <sup>31</sup>P NMR (acetone-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 12.0,\nalso observed 11.6. ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 921.1 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>34</sub>H<sub>36</sub>N<sub>2</sub>O<sub>9</sub>PReS<sub>2</sub>\u00b72H<sub>2</sub>O: C, 43.72; H, 4.32; N, 3.00. Found: C, 44.02; H, 4.26; N,\n3.02.</p>", "clean_text": "Complex 10 \n\nYield: 88 mg, 70%. IR (KBr, cm-1): 2006, 1915, 1906, 1892 (C\ue5fcO), 1722 (C\ue5fbO, amide), 1498 (C-N, S2CN) cm-1. 1H NMR (acetone-d 6, \u03b4 in ppm): 7.58-7.46 (m, 15H, ArH), 6.89 (d, J = 8.22 Hz, 1H, NH), 6.86 (d, J = 8.22 Hz, 1H, NH), 5.66 (m, 1H, NHCHCHO), 5.62 (m, 1H, NHCHCHO), 5.17 (m, 1H, NHCHCHO), 5.10 (m, 1H, NHCHCHO), 4.31-3.33 (m, 6H, S2CNCH 2,eq, glucosamine ring), 2.83 (alcohols), 2.67 (t, J =  11.04 Hz, 2H, S2CNCH 2,ax), 2.55 (m, 1H, S2CNCH2CH2CH), 1.73 (m, 2H, S2CNCH2CH 2,eq), 1.56 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (acetone-d 6, \u03b4 in ppm, except phenyl resonance): 209.8 (S2 CN), 194.2 (CO, amide), 91.4 (NHCHCHO), 76.8 (OCH(OH)CH2OH), 72.2 (NHCHCH(OH)), (NHCHCH(OH)CH(OH)), 61.8 (CH2OH), 54.7 (NHCH), 45.4 (S2CNCH2), 42.1 (S2CNCH2CH2 CH), 28.3 (S2CNCH2 CH2). 31P NMR (acetone-d 6, \u03b4 in ppm): 12.0, also observed 11.6. ESI MS (positive mode, m/z): 921.1 (M + Na+). Anal. Calcd for C34H36N2O9PReS2\u22c52H2O: C, 43.72; H, 4.32; N, 3.00. Found: C, 44.02; H, 4.26; N, 3.02.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 54, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of Complex <bold>8</bold> in Water Medium</title><p>A solution of [Re(H<sub>2</sub>O)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup> (10 ppm) was prepared according to a previously reported\nmethod and added to a suspension of <bold>4</bold> (1 mg, 2 \u03bcmol) in water (1 mL). The mixture was heated\nin a boiling water bath for 1 h. Next, triphenylphosphine (1 mg, 4\n\u03bcmol) was added and heated in a boiling water bath for an additional\n1 h. The solution was centrifuged and analyzed by ESI MS. ESI MS (positive\nion): 845.0 (M + Na<sup>+</sup>).</p>", "clean_text": "Synthesis of Complex 8 in Water Medium\n\nA solution of [Re(H2O)3(CO)3]+ (10 ppm) was prepared according to a previously reported method and added to a suspension of 4 (1 mg, 2 \u03bcmol) in water (1 mL). The mixture was heated in a boiling water bath for 1 h. Next, triphenylphosphine (1 mg, 4 \u03bcmol) was added and heated in a boiling water bath for an additional 1 h. The solution was centrifuged and analyzed by ESI MS. ESI MS (positive ion): 845.0 (M + Na+).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 55, "type": "text", "classification": ["property"], "content": "<title>Determination of Solubility of Compounds <bold>3</bold> and <bold>4</bold> in Water</title><p>A suspension in water (10 mL) of the appropriate\nZn(II) compound (<bold>3</bold> and <bold>4</bold>; 1 mg) was heated\nto 40 \u00b0C for 1 h. Next, the solution was filtered through a 0.2\n\u03bcm filter and centrifuged at 13\u2009000 rpm for 20 min. The\nresulting clear solution was diluted in 1% HNO<sub>3</sub> and the\nZn content was analyzed by means of inductively coupled plasma optical\nemission spectrometry (ICP-OES). Solubility in water: 3.1 ppm for <bold>3</bold> and 0.66 ppm for <bold>4</bold>.</p>", "clean_text": "Determination of Solubility of Compounds 3 and 4 in Water\n\nA suspension in water (10 mL) of the appropriate Zn(II) compound (3 and 4; 1 mg) was heated to 40 \u00b0C for 1 h. Next, the solution was filtered through a 0.2 \u03bcm filter and centrifuged at 13000 rpm for 20 min. The resulting clear solution was diluted in 1% HNO3 and the Zn content was analyzed by means of inductively coupled plasma optical emission spectrometry (ICP-OES). Solubility in water: 3.1 ppm for 3 and 0.66 ppm for 4.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 56, "type": "text", "classification": ["else"], "content": "<title>X-ray Crystallography</title><p>Data were collected by the <italic toggle=\"yes\">Servei de Difraccio\u0301 de Raigs X de la UAB</italic> using SMART software on a Bruker APEX CCD diffractometer\nwith graphite-monochromated Mo K\u03b1 radiation (\u03bb = 0.710\u200973\n\u00c5) at 100 K for <bold>2</bold> and at room temperature for <bold>1</bold> and <bold>8</bold>. Data reductions were performed using\nthe SAINT software. Data were corrected\nfor absorption using SADABS. Structures\nwere solved by direct methods using SHELXS-97 and refined by full-matrix least squares on <italic toggle=\"yes\">F</italic>\n<sup>2</sup> with anisotropic displacement parameters for the non-H atoms\nusing SHELXL-97. The C- and N-hydrogen\natoms were included from calculated positions and refined riding on\ntheir respective carbon or nitrogen atoms with isotropic displacement\nparameters.</p>", "clean_text": "X-ray Crystallography\n\nData were collected by the Servei de Difraccio\u0301 de Raigs X de la UAB using SMART software on a Bruker APEX CCD diffractometer with graphite-monochromated Mo K\u03b1 radiation (\u03bb = 0.71073 \u00c5) at 100 K for 2 and at room temperature for 1 and 8. Data reductions were performed using the SAINT software. Data were corrected for absorption using SADABS. Structures were solved by direct methods using SHELXS-97 and refined by full-matrix least squares on F 2 with anisotropic displacement parameters for the non-H atoms using SHELXL-97. The C- and N-hydrogen atoms were included from calculated positions and refined riding on their respective carbon or nitrogen atoms with isotropic displacement parameters.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 57, "type": "text", "classification": ["else"], "content": "<p>In the crystal structure of complex <bold>1</bold> MeOH/water disorder is present in one site. Fifteen of the eighteen\nwater hydrogen atoms were located in a difference Fourier map. In\nthe crystal structure of complex <bold>2</bold> MeCN is present, the\ndimer/MeCN ratio being 1/3. One MeCN molecule is disordered about\nan inversion center. In the crystal structure of complex <bold>8</bold> two molecules with similar conformations are present in the asymmetric\nunit.</p>", "clean_text": "In the crystal structure of complex 1 MeOH/water disorder is present in one site. Fifteen of the eighteen water hydrogen atoms were located in a difference Fourier map. In the crystal structure of complex 2 MeCN is present, the dimer/MeCN ratio being 1/3. One MeCN molecule is disordered about an inversion center. In the crystal structure of complex 8 two molecules with similar conformations are present in the asymmetric unit.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 58, "type": "text", "classification": ["else"], "content": "<p>Details of the structure solution and refinement are provided\nas  for complexes <bold>1</bold>, <bold>2</bold>, and <bold>8</bold>.</p><p>Tables of selected bond distances\nand angles, tables of crystal data and structure refinement parameters,\nellipsoid plots showing atom numbering, and CIF files giving X-ray\ncrystallographic data for structure determinations of compounds <bold>1</bold>, <bold>2</bold>, and <bold>8</bold>. This material is available\nfree of charge via the Internet at <uri xlink:href=\"http://pubs.acs.org\">http://pubs.acs.org</uri>.</p>", "clean_text": "Details of the structure solution and refinement are provided as  for complexes 1, 2, and 8.\n\nTables of selected bond distances and angles, tables of crystal data and structure refinement parameters, ellipsoid plots showing atom numbering, and CIF files giving X-ray crystallographic data for structure determinations of compounds 1, 2, and 8. This material is available free of charge via the Internet at http://pubs.acs.org.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 59, "type": "text", "classification": ["else"], "content": "<p>The authors declare no competing\nfinancial interest.</p><title>References</title>", "clean_text": "The authors declare no competing financial interest.\n\nReferences", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": "42, 43, 44, 45, 48, 49, 54", "type": "text", "classification": "synthesis condition", "content": "<title>Synthesis of Complex <bold>1</bold>\n</title><p>A solution of NaOH\n(2.8 g, 70 mmol) in water (70 mL) was added to a solution of isonipecotic\nacid (4.5 g, 35 mmol) in methanol (MeOH, 140 mL), and the resulting\nsolution was cooled to 0 \u00b0C. Carbon disulfide (2.45 mL, 40.9\nmmol) was slowly added to this cold solution, and the mixture was\nstirred at this temperature for 1 h. Next, the cooling bath was removed\nand the mixture was stirred overnight at room temperature. After this\ntime, a solution of zinc acetate (3.8 g, 17.5 mmol) in water (35 mL)\nwas added dropwise with vigorous stirring to the previous mixture\nfor a period of 4 h. The resulting solution was cooled to 4 \u00b0C,\nand colorless crystals precipitated after 12\u201324 h. This solid\nwas filtered off, washed with MeOH and Et<sub>2</sub>O, and dried\nunder vacuum, giving a white powder (8.1 g, 84% yield). IR (KBr, cm<sup>\u20131</sup>): 1553 (COO<sup>\u2013</sup>), 1493 (CN, S<sub>2</sub>CN). <sup>1</sup>H NMR (D<sub>2</sub>O, \u03b4 in ppm): 4.97\n(d, <italic toggle=\"yes\">J</italic> = 12.9 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.32 (dt, <italic toggle=\"yes\">J</italic> = 12.7 Hz, <italic toggle=\"yes\">J</italic> = 2.7 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.30 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.95 (dd, <italic toggle=\"yes\">J</italic> = 13.7 Hz, <italic toggle=\"yes\">J</italic> = 3.3 Hz, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.65 (dq, <italic toggle=\"yes\">J</italic> = 13.2 Hz, <italic toggle=\"yes\">J</italic> =  3.7 Hz, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (D<sub>2</sub>O, \u03b4 in ppm):\n201.8 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 184.1 (<italic toggle=\"yes\">C</italic>OO<sup>\u2013</sup>), 52.5 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 43.8 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 29,4 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (negative mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 493 (M \u2013 Na<sup>+</sup>). Anal. Calcd for C<sub>14</sub>H<sub>18</sub>N<sub>2</sub>Na<sub>2</sub>O<sub>4</sub>S<sub>4</sub>Zn\u00b72H<sub>2</sub>O: C, 30.35; H, 4.00; N, 5.06. Found:\nC, 30.39; H, 3.91; N, 4.97.</p><title>Synthesis of Complex <bold>2</bold>\n</title><p>\n<italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>\u2032,<italic toggle=\"yes\">N</italic>\u2032-Tetramethyl-<italic toggle=\"yes\">O</italic>-(<italic toggle=\"yes\">N</italic>-succinimidyl)uronium\ntetrafluoroborate (TSTU; 256 mg, 0.85 mmol) was added to a solution\nof complex <bold>1</bold> (200 mg, 0.36 mmol) and <italic toggle=\"yes\">N</italic>,<italic toggle=\"yes\">N</italic>-diisopropylethylamine (DIPEA; 13 \u03bcL, 0.07\nmmol) in dry dimethylformamide (DMF; 1 mL). The heterogeneous mixture\nwas stirred for 16 h, and then 140 mL of a H<sub>2</sub>O/EtOH mixture\n(1/1, v/v) was added. The crude precipitate was centrifuged and washed\nwith EtOH and Et<sub>2</sub>O to give a white solid (239 mg, 99% yield)\nthat can be recrystallized from hot acetonitrile. IR (KBr, cm<sup>\u20131</sup>): 1736 (C\ue5fbO, succinimidyl), 1634 (C\ue5fbO,\nester), 1493 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 4.73 (d, <italic toggle=\"yes\">J</italic> =  13.4 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.53 (t, <italic toggle=\"yes\">J</italic> =  12.4 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 3.22 (m, 1; H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 2.83 (s, 4H, succinimidyl),\n2.10 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.70 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 203.4 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N),\n170.1 (<italic toggle=\"yes\">C</italic>O, succinimidyl), 169.8 (<italic toggle=\"yes\">C</italic>O, ester), 49.9 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>),\n36.3 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 27.4 (<italic toggle=\"yes\">C</italic>H<sub>2</sub>, succinimidyl), 25.5 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive\nmode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 688.9 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>22</sub>H<sub>26</sub>N<sub>4</sub>O<sub>8</sub>S<sub>4</sub>Zn: C, 39.55; H, 3.92; N, 8.39. Found: C, 39.82;\nH, 3.83; N, 8.61.</p><title>Synthesis of Complexes <bold>3</bold>\u2013<bold>5</bold>\n</title><p>Complex <bold>2</bold> (1.0 g, 1.5 mmol) was dissolved in dry DMF\n(10 mL). The appropriate amine (3.8 mmol) and DIPEA (7.5 mmol) was\nadded to the solution, and the reaction mixture was stirred overnight.\nA mixture of water and EtOH (1/1, v/v) (100 mL) was added, and the\ncrude product was centrifuged and washed with the same mixture to\neliminate the excess of the amine and DIPEA. The product was dried\nunder vacuum.</p><title>Complex <bold>3</bold>\n</title><p>Yield: 678 mg, 74%. IR (KBr,\ncm<sup>\u20131</sup>): 3294 (N\u2013H, amide), 1753 (C\ue5fbO,\namide), 1646 (C\ue5fbO, ester), 1492 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm):\n8.4 (t, <italic toggle=\"yes\">J</italic> = 5.96 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 4.8\n(d, <italic toggle=\"yes\">J</italic> = 12.86 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.8 (d, <italic toggle=\"yes\">J</italic> = 5.96 Hz, 2H, NC<italic toggle=\"yes\">H</italic>\n<sub>\n<italic toggle=\"yes\">2</italic>\n</sub>CO), 3.62 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>\n<italic toggle=\"yes\">3</italic>\n</sub>), 3.31 (m, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.53 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.82 (m, 2H,\nS<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>),\n1.58 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 202.7 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 174.6\n(<italic toggle=\"yes\">C</italic>O, amide), 170.6 (NCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>O), 51.7 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 50.6 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 39.9 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.2 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 637.0 (M + Na<sup>+</sup>). Anal. Calcd for\nC<sub>20</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S<sub>4</sub>Zn: C, 38.99; H, 4.91; N, 9.09. Found: C, 38.71; H, 4.91; N, 8.92.</p><title>Synthesis of Complex <bold>6</bold>\n</title><p>The complex <bold>2</bold> (1.0 g, 1.5 mmol) was dissolved in dry DMF (10 mL). Glucosamine\nchlorhydrate (3.8 mmol) and DIPEA (3.8 mmol) was added to the solution,\nwhich was then stirred for 3 h. Methanol (100 mL) was added, and the\ncrude mixture was centrifuged and washed with the same solvent to\neliminate the excess glucosamine and DIPEA. The product was dried\nunder vacuum (550 mg, 44% yield). IR (KBr, cm<sup>\u20131</sup>):\n3411 (O\u2013H, alcohols), 1644 (C\ue5fbO, amide), 1492 (C\u2013N,\nS<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 7.69 (d, <italic toggle=\"yes\">J</italic> = 8.31 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 7.64 (d, J = 7.65 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 6.47\n(d, <italic toggle=\"yes\">J</italic> = 6.34 Hz, 1H, NHCHC<italic toggle=\"yes\">H</italic>O), 6.41\n(d, <italic toggle=\"yes\">J</italic> = 4.28 Hz, 1H, NHCHC<italic toggle=\"yes\">H</italic>O), 4.90\u20134.30\n(m, 6 H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>, glucosamine\nring), 3.60\u20133.40 (m, 5H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>, glucosamine ring), 3.31\u20133.00 (m, 2H, glucosamine\nring), 2.56 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.71 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.60 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-d<sub>6</sub>, \u03b4 in ppm, except glucosamine ring resonances): 192.5 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 163.8 (<italic toggle=\"yes\">C</italic>O, amide),\n51.2 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 40.8 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.5 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive\nmode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 817.2 (M + Na<sup>+</sup>); Anal. Calcd for C<sub>26</sub>H<sub>42</sub>N<sub>4</sub>O<sub>12</sub>S<sub>4</sub>Zn\u00b72H<sub>2</sub>O: C, 37.52; H, 5.57;\nN, 6.73. Found: C, 37.88; H, 5.42; N, 6.69.</p><title>Synthesis of Complexes <bold>7</bold>\u2013<bold>10</bold>\n</title><p>The precursor [NEt<sub>4</sub>]<sub>2</sub>[Re(CO)<sub>3</sub>Br<sub>3</sub>] (100 mg, 0.14 mmol) was dissolved in MeOH\n(10 mL) and added to a suspension of <bold>3</bold>\u2013<bold>6</bold> (0.08 mmol) in the same solvent (30 mL). The mixture was heated\nto reflux for 1 h. Next, triphenylphosphine (34 mg, 0.14 mmol) was\nadded and the resulting suspension was heated to reflux for an additional\n1 h. The clear solution that was obtained was concentrated under vacuum\nto 5 mL, and the resulting solution was cooled to 4 \u00b0C to crystallize\nthe complex. The complex was washed with cold MeOH and Et<sub>2</sub>O to give a white solid.</p><title>Synthesis of Complex <bold>8</bold> in Water Medium</title><p>A solution of [Re(H<sub>2</sub>O)<sub>3</sub>(CO)<sub>3</sub>]<sup>+</sup> (10 ppm) was prepared according to a previously reported\nmethod and added to a suspension of <bold>4</bold> (1 mg, 2 \u03bcmol) in water (1 mL). The mixture was heated\nin a boiling water bath for 1 h. Next, triphenylphosphine (1 mg, 4\n\u03bcmol) was added and heated in a boiling water bath for an additional\n1 h. The solution was centrifuged and analyzed by ESI MS. ESI MS (positive\nion): 845.0 (M + Na<sup>+</sup>).</p>", "clean_text": "Synthesis of Complex 1 \n\nA solution of NaOH (2.8 g, 70 mmol) in water (70 mL) was added to a solution of isonipecotic acid (4.5 g, 35 mmol) in methanol (MeOH, 140 mL), and the resulting solution was cooled to 0 \u00b0C. Carbon disulfide (2.45 mL, 40.9 mmol) was slowly added to this cold solution, and the mixture was stirred at this temperature for 1 h. Next, the cooling bath was removed and the mixture was stirred overnight at room temperature. After this time, a solution of zinc acetate (3.8 g, 17.5 mmol) in water (35 mL) was added dropwise with vigorous stirring to the previous mixture for a period of 4 h. The resulting solution was cooled to 4 \u00b0C, and colorless crystals precipitated after 12-24 h. This solid was filtered off, washed with MeOH and Et2O, and dried under vacuum, giving a white powder (8.1 g, 84% yield). IR (KBr, cm-1): 1553 (COO-), 1493 (CN, S2CN). 1H NMR (D2O, \u03b4 in ppm): 4.97 (d, J = 12.9 Hz, 2H, S2CNCH 2,eq), 3.32 (dt, J = 12.7 Hz, J = 2.7 Hz, 2H, S2CNCH 2,ax), 2.30 (m, 1H, S2CNCH2CH2CH), 1.95 (dd, J = 13.7 Hz, J = 3.3 Hz, 2H, S2CNCH2CH 2,eq), 1.65 (dq, J = 13.2 Hz, J =  3.7 Hz, 2H, S2CNCH2CH 2,ax). 13C NMR (D2O, \u03b4 in ppm): 201.8 (S2 CN), 184.1 (COO-), 52.5 (S2CNCH2), 43.8 (S2CNCH2CH2 CH), 29,4 (S2CNCH2 CH2). ESI MS (negative mode, m/z): 493 (M - Na+). Anal. Calcd for C14H18N2Na2O4S4Zn\u22c52H2O: C, 30.35; H, 4.00; N, 5.06. Found: C, 30.39; H, 3.91; N, 4.97.\n\nSynthesis of Complex 2 \n\n N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate (TSTU; 256 mg, 0.85 mmol) was added to a solution of complex 1 (200 mg, 0.36 mmol) and N,N-diisopropylethylamine (DIPEA; 13 \u03bcL, 0.07 mmol) in dry dimethylformamide (DMF; 1 mL). The heterogeneous mixture was stirred for 16 h, and then 140 mL of a H2O/EtOH mixture (1/1, v/v) was added. The crude precipitate was centrifuged and washed with EtOH and Et2O to give a white solid (239 mg, 99% yield) that can be recrystallized from hot acetonitrile. IR (KBr, cm-1): 1736 (C\ue5fbO, succinimidyl), 1634 (C\ue5fbO, ester), 1493 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 4.73 (d, J =  13.4 Hz, 2H, S2CNCH 2,eq), 3.53 (t, J =  12.4 Hz, 2H, S2CNCH 2,ax), 3.22 (m, 1; H, S2CNCH2CH2CH), 2.83 (s, 4H, succinimidyl), 2.10 (m, 2H, S2CNCH2CH 2,eq), 1.70 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 203.4 (S2 CN), 170.1 (CO, succinimidyl), 169.8 (CO, ester), 49.9 (S2CNCH2), 36.3 (S2CNCH2CH2 CH), 27.4 (CH2, succinimidyl), 25.5 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 688.9 (M + Na+). Anal. Calcd for C22H26N4O8S4Zn: C, 39.55; H, 3.92; N, 8.39. Found: C, 39.82; H, 3.83; N, 8.61.\n\nSynthesis of Complexes 3-5 \n\nComplex 2 (1.0 g, 1.5 mmol) was dissolved in dry DMF (10 mL). The appropriate amine (3.8 mmol) and DIPEA (7.5 mmol) was added to the solution, and the reaction mixture was stirred overnight. A mixture of water and EtOH (1/1, v/v) (100 mL) was added, and the crude product was centrifuged and washed with the same mixture to eliminate the excess of the amine and DIPEA. The product was dried under vacuum.\n\nComplex 3 \n\nYield: 678 mg, 74%. IR (KBr, cm-1): 3294 (N-H, amide), 1753 (C\ue5fbO, amide), 1646 (C\ue5fbO, ester), 1492 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 8.4 (t, J = 5.96 Hz, 1H, NH), 4.8 (d, J = 12.86 Hz, 2H, S2CNCH 2,eq), 3.8 (d, J = 5.96 Hz, 2H, NCH  2 CO), 3.62 (s, 3H, OCH  3 ), 3.31 (m, 2H, S2CNCH 2,ax), 2.53 (m, 1H, S2CNCH2CH2CH), 1.82 (m, 2H, S2CNCH2CH 2,eq), 1.58 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 202.7 (S2 CN), 174.6 (CO, amide), 170.6 (NCH2 CO), 51.7 (OCH3), 50.6 (S2CNCH2), 39.9 (S2CNCH2CH2 CH), 28.2 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 637.0 (M + Na+). Anal. Calcd for C20H30N4O6S4Zn: C, 38.99; H, 4.91; N, 9.09. Found: C, 38.71; H, 4.91; N, 8.92.\n\nSynthesis of Complex 6 \n\nThe complex 2 (1.0 g, 1.5 mmol) was dissolved in dry DMF (10 mL). Glucosamine chlorhydrate (3.8 mmol) and DIPEA (3.8 mmol) was added to the solution, which was then stirred for 3 h. Methanol (100 mL) was added, and the crude mixture was centrifuged and washed with the same solvent to eliminate the excess glucosamine and DIPEA. The product was dried under vacuum (550 mg, 44% yield). IR (KBr, cm-1): 3411 (O-H, alcohols), 1644 (C\ue5fbO, amide), 1492 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 7.69 (d, J = 8.31 Hz, 1H, NH), 7.64 (d, J = 7.65 Hz, 1H, NH), 6.47 (d, J = 6.34 Hz, 1H, NHCHCHO), 6.41 (d, J = 4.28 Hz, 1H, NHCHCHO), 4.90-4.30 (m, 6 H, S2CNCH 2,eq, glucosamine ring), 3.60-3.40 (m, 5H, S2CNCH 2,ax, glucosamine ring), 3.31-3.00 (m, 2H, glucosamine ring), 2.56 (m, 1H, S2CNCH2CH2CH), 1.71 (m, 2H, S2CNCH2CH 2,eq), 1.60 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d6, \u03b4 in ppm, except glucosamine ring resonances): 192.5 (S2 CN), 163.8 (CO, amide), 51.2 (S2CNCH2), 40.8 (S2CNCH2CH2 CH), 28.5 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 817.2 (M + Na+); Anal. Calcd for C26H42N4O12S4Zn\u22c52H2O: C, 37.52; H, 5.57; N, 6.73. Found: C, 37.88; H, 5.42; N, 6.69.\n\nSynthesis of Complexes 7-10 \n\nThe precursor [NEt4]2[Re(CO)3Br3] (100 mg, 0.14 mmol) was dissolved in MeOH (10 mL) and added to a suspension of 3-6 (0.08 mmol) in the same solvent (30 mL). The mixture was heated to reflux for 1 h. Next, triphenylphosphine (34 mg, 0.14 mmol) was added and the resulting suspension was heated to reflux for an additional 1 h. The clear solution that was obtained was concentrated under vacuum to 5 mL, and the resulting solution was cooled to 4 \u00b0C to crystallize the complex. The complex was washed with cold MeOH and Et2O to give a white solid.\n\nSynthesis of Complex 8 in Water Medium\n\nA solution of [Re(H2O)3(CO)3]+ (10 ppm) was prepared according to a previously reported method and added to a suspension of 4 (1 mg, 2 \u03bcmol) in water (1 mL). The mixture was heated in a boiling water bath for 1 h. Next, triphenylphosphine (1 mg, 4 \u03bcmol) was added and heated in a boiling water bath for an additional 1 h. The solution was centrifuged and analyzed by ESI MS. ESI MS (positive ion): 845.0 (M + Na+).", "data": [[{"meta": {"name": "Complex 1", "symbol": "1", "chemical formula": "C14H18N2Na2O4S4Zn\u22c52H2O"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "NaOH", "amount": "2.8", "unit": "g"}, {"name": "isonipecotic acid", "amount": "4.5", "unit": "g"}, {"name": "Carbon disulfide", "amount": "2.45", "unit": "mL"}, {"name": "zinc acetate", "amount": "3.8", "unit": "g"}], "solution": [{"name": "water", "amount": "70", "unit": "mL"}, {"name": "methanol", "amount": "140", "unit": "mL"}], "pressure": "", "temperature": "0 \u00b0C to room temperature", "time": "1 h to overnight"}, {"synthesis method": "washing", "washing solution": "MeOH and Et2O", "amount": ""}, {"synthesis method": "drying", "pressure": "vacuum", "temperature": "", "atmosphere": "", "time": ""}], "yield": "84%"}, {"meta": {"name": "Complex 2", "symbol": "2", "chemical formula": "C22H26N4O8S4Zn"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate", "amount": "256", "unit": "mg"}, {"name": "complex 1", "amount": "200", "unit": "mg"}, {"name": "N,N-diisopropylethylamine", "amount": "13", "unit": "\u03bcL"}], "solution": [{"name": "dry dimethylformamide", "amount": "1", "unit": "mL"}], "pressure": "", "temperature": "", "time": "16 h"}, {"synthesis method": "washing", "washing solution": "EtOH and Et2O", "amount": ""}], "yield": "99%"}, {"meta": {"name": "Complex 3", "symbol": "3", "chemical formula": "C20H30N4O6S4Zn"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "complex 2", "amount": "1.0", "unit": "g"}, {"name": "appropriate amine", "amount": "3.8", "unit": "mmol"}, {"name": "DIPEA", "amount": "7.5", "unit": "mmol"}], "solution": [{"name": "dry DMF", "amount": "10", "unit": "mL"}], "pressure": "", "temperature": "", "time": "overnight"}, {"synthesis method": "washing", "washing solution": "water and EtOH", "amount": ""}, {"synthesis method": "drying", "pressure": "vacuum", "temperature": "", "atmosphere": "", "time": ""}], "yield": "74%"}, {"meta": {"name": "Complex 6", "symbol": "6", "chemical formula": "C26H42N4O12S4Zn\u22c52H2O"}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "complex 2", "amount": "1.0", "unit": "g"}, {"name": "glucosamine chlorhydrate", "amount": "3.8", "unit": "mmol"}, {"name": "DIPEA", "amount": "3.8", "unit": "mmol"}], "solution": [{"name": "dry DMF", "amount": "10", "unit": "mL"}], "pressure": "", "temperature": "", "time": "3 h"}, {"synthesis method": "washing", "washing solution": "methanol", "amount": ""}, {"synthesis method": "drying", "pressure": "vacuum", "temperature": "", "atmosphere": "", "time": ""}], "yield": "44%"}, {"meta": {"name": "Complex 8", "symbol": "8", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "[Re(H2O)3(CO)3]+", "amount": "10", "unit": "ppm"}, {"name": "4", "amount": "1", "unit": "mg"}, {"name": "triphenylphosphine", "amount": "1", "unit": "mg"}], "solution": [{"name": "water", "amount": "1", "unit": "mL"}], "pressure": "", "temperature": "boiling water bath", "time": "2 h"}]}]], "include_properties": ["washing", "filtration", "drying", "chemical_synthesis"], "intermediate_step": {"text-synthesis-type": "['chemical_synthesis', 'filtration', 'washing', 'drying']", "text-synthesis-struct": "```JSON\n[{\"meta\":{\"name\":\"Complex 1\", \"symbol\":\"1\", \"chemical formula\":\"C14H18N2Na2O4S4Zn\u22c52H2O\"}, \"processes\":[{\"synthesis method\": \"chemical synthesis\", \"precursor\":[{\"name\":\"NaOH\", \"amount\":\"2.8\", \"unit\":\"g\"}, {\"name\":\"isonipecotic acid\", \"amount\":\"4.5\", \"unit\":\"g\"}, {\"name\":\"Carbon disulfide\", \"amount\":\"2.45\", \"unit\":\"mL\"}, {\"name\":\"zinc acetate\", \"amount\":\"3.8\", \"unit\":\"g\"}], \"solution\":[{\"name\":\"water\", \"amount\":\"70\", \"unit\":\"mL\"}, {\"name\":\"methanol\", \"amount\":\"140\", \"unit\":\"mL\"}], \"pressure\":\"\", \"temperature\":\"0 \u00b0C to room temperature\", \"time\":\"1 h to overnight\"}, {\"synthesis method\":\"washing\", \"washing solution\":\"MeOH and Et2O\", \"amount\":\"\"}, {\"synthesis method\":\"drying\", \"pressure\":\"vacuum\", \"temperature\":\"\", \"atmosphere\":\"\", \"time\":\"\"}], \"yield\":\"84%\"}, {\"meta\":{\"name\":\"Complex 2\", \"symbol\":\"2\", \"chemical formula\":\"C22H26N4O8S4Zn\"}, \"processes\":[{\"synthesis method\": \"chemical synthesis\", \"precursor\":[{\"name\":\"N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate\", \"amount\":\"256\", \"unit\":\"mg\"}, {\"name\":\"complex 1\", \"amount\":\"200\", \"unit\":\"mg\"}, {\"name\":\"N,N-diisopropylethylamine\", \"amount\":\"13\", \"unit\":\"\u03bcL\"}], \"solution\":[{\"name\":\"dry dimethylformamide\", \"amount\":\"1\", \"unit\":\"mL\"}], \"pressure\":\"\", \"temperature\":\"\", \"time\":\"16 h\"}, {\"synthesis method\":\"washing\", \"washing solution\":\"EtOH and Et2O\", \"amount\":\"\"}], \"yield\":\"99%\"}, {\"meta\":{\"name\":\"Complex 3\", \"symbol\":\"3\", \"chemical formula\":\"C20H30N4O6S4Zn\"}, \"processes\":[{\"synthesis method\": \"chemical synthesis\", \"precursor\":[{\"name\":\"complex 2\", \"amount\":\"1.0\", \"unit\":\"g\"}, {\"name\":\"appropriate amine\", \"amount\":\"3.8\", \"unit\":\"mmol\"}, {\"name\":\"DIPEA\", \"amount\":\"7.5\", \"unit\":\"mmol\"}], \"solution\":[{\"name\":\"dry DMF\", \"amount\":\"10\", \"unit\":\"mL\"}], \"pressure\":\"\", \"temperature\":\"\", \"time\":\"overnight\"}, {\"synthesis method\":\"washing\", \"washing solution\":\"water and EtOH\", \"amount\":\"\"}, {\"synthesis method\":\"drying\", \"pressure\":\"vacuum\", \"temperature\":\"\", \"atmosphere\":\"\", \"time\":\"\"}], \"yield\":\"74%\"}, {\"meta\":{\"name\":\"Complex 6\", \"symbol\":\"6\", \"chemical formula\":\"C26H42N4O12S4Zn\u22c52H2O\"}, \"processes\":[{\"synthesis method\": \"chemical synthesis\", \"precursor\":[{\"name\":\"complex 2\", \"amount\":\"1.0\", \"unit\":\"g\"}, {\"name\":\"glucosamine chlorhydrate\", \"amount\":\"3.8\", \"unit\":\"mmol\"}, {\"name\":\"DIPEA\", \"amount\":\"3.8\", \"unit\":\"mmol\"}], \"solution\":[{\"name\":\"dry DMF\", \"amount\":\"10\", \"unit\":\"mL\"}], \"pressure\":\"\", \"temperature\":\"\", \"time\":\"3 h\"}, {\"synthesis method\":\"washing\", \"washing solution\":\"methanol\", \"amount\":\"\"}, {\"synthesis method\":\"drying\", \"pressure\":\"vacuum\", \"temperature\":\"\", \"atmosphere\":\"\", \"time\":\"\"}], \"yield\":\"44%\"}, {\"meta\":{\"name\":\"Complex 8\", \"symbol\":\"8\", \"chemical formula\":\"\"}, \"processes\":[{\"synthesis method\": \"chemical synthesis\", \"precursor\":[{\"name\":\"[Re(H2O)3(CO)3]+\", \"amount\":\"10\", \"unit\":\"ppm\"}, {\"name\":\"4\", \"amount\":\"1\", \"unit\":\"mg\"}, {\"name\":\"triphenylphosphine\", \"amount\":\"1\", \"unit\":\"mg\"}], \"solution\":[{\"name\":\"water\", \"amount\":\"1\", \"unit\":\"mL\"}], \"pressure\":\"\", \"temperature\":\"boiling water bath\", \"time\":\"2 h\"}]}]\n```"}}, {"idx": "45, 46, 47, 50", "type": "text", "classification": "property", "content": "<title>Complex <bold>3</bold>\n</title><p>Yield: 678 mg, 74%. IR (KBr,\ncm<sup>\u20131</sup>): 3294 (N\u2013H, amide), 1753 (C\ue5fbO,\namide), 1646 (C\ue5fbO, ester), 1492 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm):\n8.4 (t, <italic toggle=\"yes\">J</italic> = 5.96 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 4.8\n(d, <italic toggle=\"yes\">J</italic> = 12.86 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.8 (d, <italic toggle=\"yes\">J</italic> = 5.96 Hz, 2H, NC<italic toggle=\"yes\">H</italic>\n<sub>\n<italic toggle=\"yes\">2</italic>\n</sub>CO), 3.62 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>\n<italic toggle=\"yes\">3</italic>\n</sub>), 3.31 (m, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.53 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.82 (m, 2H,\nS<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>),\n1.58 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 202.7 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 174.6\n(<italic toggle=\"yes\">C</italic>O, amide), 170.6 (NCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>O), 51.7 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 50.6 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 39.9 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.2 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 637.0 (M + Na<sup>+</sup>). Anal. Calcd for\nC<sub>20</sub>H<sub>30</sub>N<sub>4</sub>O<sub>6</sub>S<sub>4</sub>Zn: C, 38.99; H, 4.91; N, 9.09. Found: C, 38.71; H, 4.91; N, 8.92.</p><title>Complex <bold>4</bold>\n</title><p>Yield: 580 mg, 58%. IR (KBr,\ncm<sup>\u20131</sup>): 3271 (N\u2013H, amide), 1746 (C\ue5fbO,\namide), 1640 (C\ue5fbO, ester), 1492 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm):\n8.0 (t, <italic toggle=\"yes\">J</italic> = 5.41 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 4.8\n(d, <italic toggle=\"yes\">J</italic> = 12.6 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.60 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>3</sub>),\n3.27 (m, 4H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>ax</sub>, NCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CO), 2.45 (m, 3H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>, NC<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CH<sub>2</sub>CO), 1.76 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.57 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 202.7\n(S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 174.0 (<italic toggle=\"yes\">C</italic>O, amide),\n172.2 (NHCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>O), 51.8 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 51.1 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 40.6 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 35.1 (NHCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>CO), 34.0 (NH<italic toggle=\"yes\">C</italic>H<sub>2</sub>CH<sub>2</sub>CO), 28.7 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>):\n665.1 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>22</sub>H<sub>34</sub>N<sub>4</sub>O<sub>6</sub>S<sub>4</sub>Zn\u00b7H<sub>2</sub>O: C,\n39.90;; H, 5.48; N, 8.46. Found: C, 39.96; H, 5.37; N, 8.41.</p><title>Complex <bold>5</bold>\n</title><p>Yield: 870 mg, 71%. IR (KBr,\ncm<sup>\u20131</sup>): 1639 (C\ue5fbO, amide), 1436 (C\u2013N,\nS<sub>2</sub>CN). <sup>1</sup>H NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 6.96\u20136.89 (m, 4H, ArH), 4.87 (d, <italic toggle=\"yes\">J</italic> =  12.26 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.79 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>\n<italic toggle=\"yes\">3</italic>\n</sub>), 3.68 (s, 2 H, piperazine ring), 3.60 (s, 2H, piperazine\nring), 3.40 (m, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 3.05 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 2.97 (s, 2H, piperazine ring), 2.90 (s, 2H, piperazine\nring), 1.80 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.59 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (DMSO-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 202.6 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 172.0 (<italic toggle=\"yes\">C</italic>O, amide), 152.0\u2013111.9 (ArH),\n55.4 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 50.8 (piperazine ring), 50.6\n(S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 50.2 (piperazine\nring), 45.2 (piperazine ring), 41.4 (piperazine ring), 35.6 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.3 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). ESI MS (positive\nmode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 843.4 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>36</sub>H<sub>48</sub>N<sub>6</sub>O<sub>4</sub>S<sub>4</sub>Zn: C, 52.57; H, 5.88; N, 10.22. Found: C, 52.24;\nH, 5.82; N, 9.86.</p><title>Complex <bold>7</bold>\n</title><p>Yield: 58 mg, 51%. IR (KBr,\ncm<sup>\u20131</sup>): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723\n(C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (CDCl<sub>3</sub>, \u03b4 in ppm):\n7.53\u20137.28 (m, 15 H, ArH), 5.92 (t, <italic toggle=\"yes\">J</italic> = 5.07\nHz, 1H, N<italic toggle=\"yes\">H</italic>), 4.31 (d, <italic toggle=\"yes\">J</italic> = 13.81\nHz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), also observed\n4.21 (d, <italic toggle=\"yes\">J</italic> = 13.81 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 4.05 (d, <italic toggle=\"yes\">J</italic> = 5.07 Hz,\n2H, NC<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CO), 3.81 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>3</sub>), 2.74 (t, <italic toggle=\"yes\">J</italic> = 11.96 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), also observed 2.50\n(t, <italic toggle=\"yes\">J</italic> = 11.96 Hz, 2 H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.28 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.67 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.30 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, \u03b4 in ppm, except phenyl resonances): 210.1 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 193.2\u2013190.4 (carbonyls), 173.7\n(amide), 170.5 (ester), 51.6 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 43.4\n(S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>\n<italic toggle=\"yes\">2</italic>\n</sub>CH<sub>2</sub>CH), 41.3 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 40.4 (N<italic toggle=\"yes\">C</italic>H<sub>2</sub>CO), 26.6 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>CH). <sup>31</sup>P NMR (CDCl<sub>3</sub>, \u03b4 in ppm): 14.8, also observed 14.4.\nESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 831.0\n(M + Na<sup>+</sup>); Anal. Calcd for C<sub>31</sub>H<sub>30</sub>N<sub>2</sub>O<sub>6</sub>PReS<sub>2</sub>\u00b7H<sub>2</sub>O: C,\n45.08; H, 3.91; N, 3.39. Found: C, 45.24; H, 4.08; N, 3.53.</p>", "clean_text": "Complex 3 \n\nYield: 678 mg, 74%. IR (KBr, cm-1): 3294 (N-H, amide), 1753 (C\ue5fbO, amide), 1646 (C\ue5fbO, ester), 1492 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 8.4 (t, J = 5.96 Hz, 1H, NH), 4.8 (d, J = 12.86 Hz, 2H, S2CNCH 2,eq), 3.8 (d, J = 5.96 Hz, 2H, NCH  2 CO), 3.62 (s, 3H, OCH  3 ), 3.31 (m, 2H, S2CNCH 2,ax), 2.53 (m, 1H, S2CNCH2CH2CH), 1.82 (m, 2H, S2CNCH2CH 2,eq), 1.58 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 202.7 (S2 CN), 174.6 (CO, amide), 170.6 (NCH2 CO), 51.7 (OCH3), 50.6 (S2CNCH2), 39.9 (S2CNCH2CH2 CH), 28.2 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 637.0 (M + Na+). Anal. Calcd for C20H30N4O6S4Zn: C, 38.99; H, 4.91; N, 9.09. Found: C, 38.71; H, 4.91; N, 8.92.\n\nComplex 4 \n\nYield: 580 mg, 58%. IR (KBr, cm-1): 3271 (N-H, amide), 1746 (C\ue5fbO, amide), 1640 (C\ue5fbO, ester), 1492 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 8.0 (t, J = 5.41 Hz, 1H, NH), 4.8 (d, J = 12.6 Hz, 2H, S2CNCH 2,eq), 3.60 (s, 3H, OCH 3), 3.27 (m, 4H, S2CNCH ax, NCH2CH 2CO), 2.45 (m, 3H, S2CNCH2CH2CH, NCH 2CH2CO), 1.76 (m, 2H, S2CNCH2CH 2,eq), 1.57 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 202.7 (S2 CN), 174.0 (CO, amide), 172.2 (NHCH2CH2 CO), 51.8 (OCH3), 51.1 (S2CNCH2), 40.6 (S2CNCH2CH2 CH), 35.1 (NHCH2 CH2CO), 34.0 (NHCH2CH2CO), 28.7 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 665.1 (M + Na+). Anal. Calcd for C22H34N4O6S4Zn\u22c5H2O: C, 39.90;; H, 5.48; N, 8.46. Found: C, 39.96; H, 5.37; N, 8.41.\n\nComplex 5 \n\nYield: 870 mg, 71%. IR (KBr, cm-1): 1639 (C\ue5fbO, amide), 1436 (C-N, S2CN). 1H NMR (DMSO-d 6, \u03b4 in ppm): 6.96-6.89 (m, 4H, ArH), 4.87 (d, J =  12.26 Hz, 2H, S2CNCH 2,eq), 3.79 (s, 3H, OCH  3 ), 3.68 (s, 2 H, piperazine ring), 3.60 (s, 2H, piperazine ring), 3.40 (m, 2H, S2CNCH 2,ax), 3.05 (m, 1H, S2CNCH2CH2CH), 2.97 (s, 2H, piperazine ring), 2.90 (s, 2H, piperazine ring), 1.80 (m, 2H, S2CNCH2CH 2,eq), 1.59 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (DMSO-d 6, \u03b4 in ppm): 202.6 (S2 CN), 172.0 (CO, amide), 152.0-111.9 (ArH), 55.4 (OCH3), 50.8 (piperazine ring), 50.6 (S2CNCH2), 50.2 (piperazine ring), 45.2 (piperazine ring), 41.4 (piperazine ring), 35.6 (S2CNCH2CH2 CH), 28.3 (S2CNCH2 CH2). ESI MS (positive mode, m/z): 843.4 (M + Na+). Anal. Calcd for C36H48N6O4S4Zn: C, 52.57; H, 5.88; N, 10.22. Found: C, 52.24; H, 5.82; N, 9.86.\n\nComplex 7 \n\nYield: 58 mg, 51%. IR (KBr, cm-1): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723 (C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C-N, S2CN). 1H NMR (CDCl3, \u03b4 in ppm): 7.53-7.28 (m, 15 H, ArH), 5.92 (t, J = 5.07 Hz, 1H, NH), 4.31 (d, J = 13.81 Hz, 2H, S2CNCH 2,eq), also observed 4.21 (d, J = 13.81 Hz, 2H, S2CNCH 2,eq), 4.05 (d, J = 5.07 Hz, 2H, NCH 2CO), 3.81 (s, 3H, OCH 3), 2.74 (t, J = 11.96 Hz, 2H, S2CNCH 2,ax), also observed 2.50 (t, J = 11.96 Hz, 2 H, S2CNCH 2,ax), 2.28 (m, 1H, S2CNCH2CH2CH), 1.67 (m, 2H, S2CNCH2CH 2,eq), 1.30 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (CDCl3, \u03b4 in ppm, except phenyl resonances): 210.1 (S2 CN), 193.2-190.4 (carbonyls), 173.7 (amide), 170.5 (ester), 51.6 (OCH3), 43.4 (S2CNCH 2 CH2CH), 41.3 (S2CNCH2CH2 CH), 40.4 (NCH2CO), 26.6 (S2CNCH2 CH2CH). 31P NMR (CDCl3, \u03b4 in ppm): 14.8, also observed 14.4. ESI MS (positive mode, m/z): 831.0 (M + Na+); Anal. Calcd for C31H30N2O6PReS2\u22c5H2O: C, 45.08; H, 3.91; N, 3.39. Found: C, 45.24; H, 4.08; N, 3.53.", "data": [[[{"meta": {"name": "Complex 3", "symbol": "3", "chemical formula": "C20H30N4O6S4Zn"}, "chemical formula weight": [{"value": "637.0", "unit": "g/mol", "condition": "ESI MS (positive mode, m/z)"}]}, {"meta": {"name": "Complex 4", "symbol": "4", "chemical formula": "C22H34N4O6S4Zn\u22c5H2O"}, "chemical formula weight": [{"value": "665.1", "unit": "g/mol", "condition": "ESI MS (positive mode, m/z)"}]}, {"meta": {"name": "Complex 5", "symbol": "5", "chemical formula": "C36H48N6O4S4Zn"}, "chemical formula weight": [{"value": "843.4", "unit": "g/mol", "condition": "ESI MS (positive mode, m/z)"}]}, {"meta": {"name": "Complex 7", "symbol": "7", "chemical formula": "C31H30N2O6PReS2\u22c5H2O"}, "chemical formula weight": [{"value": "831.0", "unit": "g/mol", "condition": "ESI MS (positive mode, m/z)"}]}]]], "include_properties": ["chemical_formula_weight"], "intermediate_step": {"categorize": "['synthesis condition', 'property']", "text-property-type": "['chemical_formula_weight']", "text-property-extract": "```JSON\n[\n  {\n    \"meta\": {\n      \"name\": \"Complex 3\",\n      \"symbol\": \"3\",\n      \"chemical formula\": \"C20H30N4O6S4Zn\"\n    },\n    \"chemical formula weight\": [\n      {\n        \"value\": \"637.0\",\n        \"unit\": \"g/mol\",\n        \"condition\": \"ESI MS (positive mode, m/z)\"\n      }\n    ]\n  },\n  {\n    \"meta\": {\n      \"name\": \"Complex 4\",\n      \"symbol\": \"4\",\n      \"chemical formula\": \"C22H34N4O6S4Zn\u22c5H2O\"\n    },\n    \"chemical formula weight\": [\n      {\n        \"value\": \"665.1\",\n        \"unit\": \"g/mol\",\n        \"condition\": \"ESI MS (positive mode, m/z)\"\n      }\n    ]\n  },\n  {\n    \"meta\": {\n      \"name\": \"Complex 5\",\n      \"symbol\": \"5\",\n      \"chemical formula\": \"C36H48N6O4S4Zn\"\n    },\n    \"chemical formula weight\": [\n      {\n        \"value\": \"843.4\",\n        \"unit\": \"g/mol\",\n        \"condition\": \"ESI MS (positive mode, m/z)\"\n      }\n    ]\n  },\n  {\n    \"meta\": {\n      \"name\": \"Complex 7\",\n      \"symbol\": \"7\",\n      \"chemical formula\": \"C31H30N2O6PReS2\u22c5H2O\"\n    },\n    \"chemical formula weight\": [\n      {\n        \"value\": \"831.0\",\n        \"unit\": \"g/mol\",\n        \"condition\": \"ESI MS (positive mode, m/z)\"\n      }\n    ]\n  }\n]\n```"}}, {"idx": "51, 52, 53, 55", "type": "text", "classification": "property", "content": "<title>Complex <bold>8</bold>\n</title><p>Yield: 45 mg, 40%. IR (KBr,\ncm<sup>\u20131</sup>): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723\n(C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (CDCl<sub>3</sub>, \u03b4 in ppm):\n7.53\u20137.28 (m, 15 H, ArH), 6.10 (m, 1H, N<italic toggle=\"yes\">H</italic>),\n4.31 (d, <italic toggle=\"yes\">J</italic> =  13.54 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), also observed 4.21 (d, <italic toggle=\"yes\">J</italic> =  13.54 Hz, 2 H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.71 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>3</sub>), 3.55 (q, <italic toggle=\"yes\">J</italic> =  5.81 Hz, 2H, NC<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CH<sub>2</sub>CO), 2.70 (t, <italic toggle=\"yes\">J</italic> =  13.54 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), also observed 2.40 (t, <italic toggle=\"yes\">J</italic> =  13.54 Hz, 2 H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.56 (q, <italic toggle=\"yes\">J</italic> =  5.81 Hz, 2H, NCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2</sub>CO), 2.17 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.68 (m, 2H,\nS<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>),\n1.26 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, \u03b4 in ppm,\nexcept phenyl resonances): 210.9 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N),\n193.2\u2013190.4 (carbonyls), 174.2 (amide), 44.5 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>\n<italic toggle=\"yes\">2</italic>\n</sub>), 34.9 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 33.8 (N<italic toggle=\"yes\">C</italic>H<sub>2</sub>CH<sub>2</sub>CO), 33.7 (NCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>CO),\n29.8 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 27.6 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). <sup>31</sup>P NMR (CDCl<sub>3</sub>, \u03b4 in ppm): 15.3, also\nobserved 14.7. ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 845.0 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>32</sub>H<sub>32</sub>N<sub>2</sub>O<sub>6</sub>PReS<sub>2</sub>: C, 46.76; H,\n3.92; N, 3.41. Found: C, 46.68; H, 4.00; N, 3.34.</p><title>Complex <bold>9</bold>\n</title><p>Yield: 74 mg, 58%. IR (KBr,\ncm<sup>\u20131</sup>): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723\n(C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C\u2013N, S<sub>2</sub>CN). <sup>1</sup>H NMR (CDCl<sub>3</sub>, \u03b4 in ppm):\n7.55\u20136.87 (m, 19H, ArH), 4.31 (d, <italic toggle=\"yes\">J</italic> =  13.05\nHz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), also observed\n4.21 (d, <italic toggle=\"yes\">J</italic> =  13.05 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 3.88 (s, 3H, OC<italic toggle=\"yes\">H</italic>\n<sub>3</sub>), 3.82 s, 2H, piperazine ring), 3.66 (s, 2H, piperazine ring),\n3.10 (s, 4H, piperazine ring), 2.77 (t, <italic toggle=\"yes\">J</italic> =  11.51\nHz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), also observed\n2.53 (t, <italic toggle=\"yes\">J</italic> =  11.51 Hz, 2H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.66 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.65 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.44 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>, \u03b4 in ppm, except phenyl resonances):\n211.0 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 193.4\u2013190.3 (carbonyls),\n172.2 (amide), 55.6 (O<italic toggle=\"yes\">C</italic>H<sub>3</sub>), 51.4 (piperazine\nring), 44.5 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 37.6\n(S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H),\n27.4 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). <sup>31</sup>P NMR (CDCl<sub>3</sub>, \u03b4 in ppm): 15.3, also\nobserved 14.7. ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 912.0 (M + H<sup>+</sup>). Anal. Calcd for C<sub>39</sub>H<sub>39</sub>N<sub>3</sub>O<sub>4</sub>PReS<sub>2</sub>\u00b7H<sub>2</sub>O: C, 50.42; H, 4.45; N, 4.52. Found: C, 50.55; H, 4.43; N, 4.52.</p><title>Complex <bold>10</bold>\n</title><p>Yield: 88 mg, 70%. IR (KBr,\ncm<sup>\u20131</sup>): 2006, 1915, 1906, 1892 (C\ue5fcO), 1722\n(C\ue5fbO, amide), 1498 (C\u2013N, S<sub>2</sub>CN) cm<sup>\u20131</sup>. <sup>1</sup>H NMR (acetone-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4\nin ppm): 7.58\u20137.46 (m, 15H, ArH), 6.89 (d, <italic toggle=\"yes\">J</italic> = 8.22 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 6.86 (d, <italic toggle=\"yes\">J</italic> = 8.22 Hz, 1H, N<italic toggle=\"yes\">H</italic>), 5.66 (m, 1H, NHCHC<italic toggle=\"yes\">H</italic>O), 5.62 (m, 1H, NHCHC<italic toggle=\"yes\">H</italic>O), 5.17 (m, 1H, NHC<italic toggle=\"yes\">H</italic>CHO), 5.10 (m, 1H, NHC<italic toggle=\"yes\">H</italic>CHO), 4.31\u20133.33\n(m, 6H, S<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>, glucosamine\nring), 2.83 (alcohols), 2.67 (t, <italic toggle=\"yes\">J</italic> =  11.04 Hz, 2H,\nS<sub>2</sub>CNC<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>), 2.55 (m, 1H, S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>C<italic toggle=\"yes\">H</italic>), 1.73 (m,\n2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,eq</sub>), 1.56 (m, 2H, S<sub>2</sub>CNCH<sub>2</sub>C<italic toggle=\"yes\">H</italic>\n<sub>2,ax</sub>). <sup>13</sup>C NMR (acetone-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm, except phenyl resonance): 209.8 (S<sub>2</sub>\n<italic toggle=\"yes\">C</italic>N), 194.2 (<italic toggle=\"yes\">C</italic>O, amide), 91.4 (NHCH<italic toggle=\"yes\">C</italic>HO), 76.8 (O<italic toggle=\"yes\">C</italic>H(OH)CH<sub>2</sub>OH), 72.2\n(NHCH<italic toggle=\"yes\">C</italic>H(OH)), (NHCHCH(OH)<italic toggle=\"yes\">C</italic>H(OH)),\n61.8 (<italic toggle=\"yes\">C</italic>H<sub>2</sub>OH), 54.7 (NH<italic toggle=\"yes\">C</italic>H), 45.4 (S<sub>2</sub>CN<italic toggle=\"yes\">C</italic>H<sub>2</sub>), 42.1 (S<sub>2</sub>CNCH<sub>2</sub>CH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H), 28.3 (S<sub>2</sub>CNCH<sub>2</sub>\n<italic toggle=\"yes\">C</italic>H<sub>2</sub>). <sup>31</sup>P NMR (acetone-<italic toggle=\"yes\">d</italic>\n<sub>6</sub>, \u03b4 in ppm): 12.0,\nalso observed 11.6. ESI MS (positive mode, <italic toggle=\"yes\">m</italic>/<italic toggle=\"yes\">z</italic>): 921.1 (M + Na<sup>+</sup>). Anal. Calcd for C<sub>34</sub>H<sub>36</sub>N<sub>2</sub>O<sub>9</sub>PReS<sub>2</sub>\u00b72H<sub>2</sub>O: C, 43.72; H, 4.32; N, 3.00. Found: C, 44.02; H, 4.26; N,\n3.02.</p><title>Determination of Solubility of Compounds <bold>3</bold> and <bold>4</bold> in Water</title><p>A suspension in water (10 mL) of the appropriate\nZn(II) compound (<bold>3</bold> and <bold>4</bold>; 1 mg) was heated\nto 40 \u00b0C for 1 h. Next, the solution was filtered through a 0.2\n\u03bcm filter and centrifuged at 13\u2009000 rpm for 20 min. The\nresulting clear solution was diluted in 1% HNO<sub>3</sub> and the\nZn content was analyzed by means of inductively coupled plasma optical\nemission spectrometry (ICP-OES). Solubility in water: 3.1 ppm for <bold>3</bold> and 0.66 ppm for <bold>4</bold>.</p>", "clean_text": "Complex 8 \n\nYield: 45 mg, 40%. IR (KBr, cm-1): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723 (C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C-N, S2CN). 1H NMR (CDCl3, \u03b4 in ppm): 7.53-7.28 (m, 15 H, ArH), 6.10 (m, 1H, NH), 4.31 (d, J =  13.54 Hz, 2H, S2CNCH 2,eq), also observed 4.21 (d, J =  13.54 Hz, 2 H, S2CNCH 2,eq), 3.71 (s, 3H, OCH 3), 3.55 (q, J =  5.81 Hz, 2H, NCH 2CH2CO), 2.70 (t, J =  13.54 Hz, 2H, S2CNCH 2,ax), also observed 2.40 (t, J =  13.54 Hz, 2 H, S2CNCH 2,ax), 2.56 (q, J =  5.81 Hz, 2H, NCH2CH 2CO), 2.17 (m, 1H, S2CNCH2CH2CH), 1.68 (m, 2H, S2CNCH2CH 2,eq), 1.26 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (CDCl3, \u03b4 in ppm, except phenyl resonances): 210.9 (S2 CN), 193.2-190.4 (carbonyls), 174.2 (amide), 44.5 (S2CNCH 2 ), 34.9 (OCH3), 33.8 (NCH2CH2CO), 33.7 (NCH2 CH2CO), 29.8 (S2CNCH2CH2 CH), 27.6 (S2CNCH2 CH2). 31P NMR (CDCl3, \u03b4 in ppm): 15.3, also observed 14.7. ESI MS (positive mode, m/z): 845.0 (M + Na+). Anal. Calcd for C32H32N2O6PReS2: C, 46.76; H, 3.92; N, 3.41. Found: C, 46.68; H, 4.00; N, 3.34.\n\nComplex 9 \n\nYield: 74 mg, 58%. IR (KBr, cm-1): 2009, 1912, 1905, 1892 (C\ue5fcO), 1723 (C\ue5fbO, amide), 1678 (C\ue5fbO, ester), 1497 (C-N, S2CN). 1H NMR (CDCl3, \u03b4 in ppm): 7.55-6.87 (m, 19H, ArH), 4.31 (d, J =  13.05 Hz, 2H, S2CNCH 2,eq), also observed 4.21 (d, J =  13.05 Hz, 2H, S2CNCH 2,eq), 3.88 (s, 3H, OCH 3), 3.82 s, 2H, piperazine ring), 3.66 (s, 2H, piperazine ring), 3.10 (s, 4H, piperazine ring), 2.77 (t, J =  11.51 Hz, 2H, S2CNCH 2,ax), also observed 2.53 (t, J =  11.51 Hz, 2H, S2CNCH 2,ax), 2.66 (m, 1H, S2CNCH2CH2CH), 1.65 (m, 2H, S2CNCH2CH 2,eq), 1.44 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (CDCl3, \u03b4 in ppm, except phenyl resonances): 211.0 (S2 CN), 193.4-190.3 (carbonyls), 172.2 (amide), 55.6 (OCH3), 51.4 (piperazine ring), 44.5 (S2CNCH2), 37.6 (S2CNCH2CH2 CH), 27.4 (S2CNCH2 CH2). 31P NMR (CDCl3, \u03b4 in ppm): 15.3, also observed 14.7. ESI MS (positive mode, m/z): 912.0 (M + H+). Anal. Calcd for C39H39N3O4PReS2\u22c5H2O: C, 50.42; H, 4.45; N, 4.52. Found: C, 50.55; H, 4.43; N, 4.52.\n\nComplex 10 \n\nYield: 88 mg, 70%. IR (KBr, cm-1): 2006, 1915, 1906, 1892 (C\ue5fcO), 1722 (C\ue5fbO, amide), 1498 (C-N, S2CN) cm-1. 1H NMR (acetone-d 6, \u03b4 in ppm): 7.58-7.46 (m, 15H, ArH), 6.89 (d, J = 8.22 Hz, 1H, NH), 6.86 (d, J = 8.22 Hz, 1H, NH), 5.66 (m, 1H, NHCHCHO), 5.62 (m, 1H, NHCHCHO), 5.17 (m, 1H, NHCHCHO), 5.10 (m, 1H, NHCHCHO), 4.31-3.33 (m, 6H, S2CNCH 2,eq, glucosamine ring), 2.83 (alcohols), 2.67 (t, J =  11.04 Hz, 2H, S2CNCH 2,ax), 2.55 (m, 1H, S2CNCH2CH2CH), 1.73 (m, 2H, S2CNCH2CH 2,eq), 1.56 (m, 2H, S2CNCH2CH 2,ax). 13C NMR (acetone-d 6, \u03b4 in ppm, except phenyl resonance): 209.8 (S2 CN), 194.2 (CO, amide), 91.4 (NHCHCHO), 76.8 (OCH(OH)CH2OH), 72.2 (NHCHCH(OH)), (NHCHCH(OH)CH(OH)), 61.8 (CH2OH), 54.7 (NHCH), 45.4 (S2CNCH2), 42.1 (S2CNCH2CH2 CH), 28.3 (S2CNCH2 CH2). 31P NMR (acetone-d 6, \u03b4 in ppm): 12.0, also observed 11.6. ESI MS (positive mode, m/z): 921.1 (M + Na+). Anal. Calcd for C34H36N2O9PReS2\u22c52H2O: C, 43.72; H, 4.32; N, 3.00. Found: C, 44.02; H, 4.26; N, 3.02.\n\nDetermination of Solubility of Compounds 3 and 4 in Water\n\nA suspension in water (10 mL) of the appropriate Zn(II) compound (3 and 4; 1 mg) was heated to 40 \u00b0C for 1 h. Next, the solution was filtered through a 0.2 \u03bcm filter and centrifuged at 13000 rpm for 20 min. The resulting clear solution was diluted in 1% HNO3 and the Zn content was analyzed by means of inductively coupled plasma optical emission spectrometry (ICP-OES). Solubility in water: 3.1 ppm for 3 and 0.66 ppm for 4.", "data": [[[{"meta": {"name": "Complex 8", "symbol": "", "chemical formula": "C32H32N2O6PReS2"}, "etc": [{"property name": "Yield", "value": "45 mg, 40%", "unit": "", "condition": ""}]}, {"meta": {"name": "Complex 9", "symbol": "", "chemical formula": "C39H39N3O4PReS2\u22c5H2O"}, "etc": [{"property name": "Yield", "value": "74 mg, 58%", "unit": "", "condition": ""}]}, {"meta": {"name": "Complex 10", "symbol": "", "chemical formula": "C34H36N2O9PReS2\u22c52H2O"}, "etc": [{"property name": "Yield", "value": "88 mg, 70%", "unit": "", "condition": ""}]}, {"meta": {"name": "Compound 3", "symbol": "3", "chemical formula": ""}, "etc": [{"property name": "Solubility in water", "value": "3.1", "unit": "ppm", "condition": "heated to 40 \u00b0C for 1 h"}]}, {"meta": {"name": "Compound 4", "symbol": "4", "chemical formula": ""}, "etc": [{"property name": "Solubility in water", "value": "0.66", "unit": "ppm", "condition": "heated to 40 \u00b0C for 1 h"}]}]]], "include_properties": ["etc"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['etc']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"Complex 8\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C32H32N2O6PReS2\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Yield\",\n                \"value\": \"45 mg, 40%\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"Complex 9\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C39H39N3O4PReS2\u22c5H2O\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Yield\",\n                \"value\": \"74 mg, 58%\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"Complex 10\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C34H36N2O9PReS2\u22c52H2O\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Yield\",\n                \"value\": \"88 mg, 70%\",\n                \"unit\": \"\",\n                \"condition\": \"\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"Compound 3\",\n            \"symbol\": \"3\",\n            \"chemical formula\": \"\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Solubility in water\",\n                \"value\": \"3.1\",\n                \"unit\": \"ppm\",\n                \"condition\": \"heated to 40 \u00b0C for 1 h\"\n            }\n        ]\n    },\n    {\n        \"meta\": {\n            \"name\": \"Compound 4\",\n            \"symbol\": \"4\",\n            \"chemical formula\": \"\"\n        },\n        \"etc\": [\n            {\n                \"property name\": \"Solubility in water\",\n                \"value\": \"0.66\",\n                \"unit\": \"ppm\",\n                \"condition\": \"heated to 40 \u00b0C for 1 h\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 6, "type": "figure", "classification": null, "content": "<fig id=\"fig1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Schematic representation of the competition between labeled and unlabeled\nmolecules for receptor sites after a labeling reaction.</p>\n</caption>\n<graphic id=\"gr8\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Schematic representation of the competition between labeled and unlabeled molecules for receptor sites after a labeling reaction.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 8, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" orientation=\"portrait\" position=\"float\">\n<label>1</label>\n<graphic id=\"gr1\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0005.tif\"></graphic>\n</fig>", "clean_text": " 1  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 15, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<graphic id=\"gr2\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0006.tif\"></graphic>\n</fig>", "clean_text": " 2  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<graphic id=\"gr3\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0007.tif\"></graphic>\n</fig>", "clean_text": " 3  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 19, "type": "figure", "classification": null, "content": "<fig id=\"fig2\" orientation=\"portrait\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Perspective\nview of the centrosymmetric dimeric anion [Zn<sub>2</sub>(S<sub>2</sub>CNC<sub>5</sub>H<sub>9</sub>COO)<sub>4</sub>]<sup>4\u2013</sup> of complex <bold>1</bold>. Hydrogen atoms have been omitted for\nclarity.</p>\n</caption>\n<graphic id=\"gr9\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  Perspective view of the centrosymmetric dimeric anion [Zn2(S2CNC5H9COO)4]4- of complex 1. Hydrogen atoms have been omitted for clarity.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 21, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<graphic id=\"gr4\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0008.tif\"></graphic>\n</fig>", "clean_text": " 4  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "figure", "classification": null, "content": "<fig id=\"fig3\" orientation=\"portrait\" position=\"float\">\n<label>3</label>\n<caption>\n<p>Perspective view of the centrosymmetric\ndimeric complex <bold>2</bold>. Hydrogen atoms have been omitted for\nclarity.</p>\n</caption>\n<graphic id=\"gr10\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  Perspective view of the centrosymmetric dimeric complex 2. Hydrogen atoms have been omitted for clarity.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch5\" orientation=\"portrait\" position=\"float\">\n<label>5</label>\n<graphic id=\"gr5\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0009.tif\"></graphic>\n</fig>", "clean_text": " 5  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 32, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch6\" orientation=\"portrait\" position=\"float\">\n<label>6</label>\n<graphic id=\"gr6\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0010.tif\"></graphic>\n</fig>", "clean_text": " 6  ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 35, "type": "figure", "classification": null, "content": "<fig id=\"fig4\" orientation=\"portrait\" position=\"float\">\n<label>4</label>\n<caption>\n<p>Perspective\nview of complex <bold>8</bold>. Hydrogen atoms have been omitted for\nclarity.</p>\n</caption>\n<graphic id=\"gr11\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  Perspective view of complex 8. Hydrogen atoms have been omitted for clarity.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 38, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch7\" orientation=\"portrait\" position=\"float\">\n<label>7</label>\n<graphic id=\"gr7\" orientation=\"portrait\" position=\"float\" xlink:href=\"om-2012-00394v_0011.tif\"></graphic>\n</fig>", "clean_text": " 7  ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/om300394v", "title": "\nNew Bioconjugated Rhenium\nCarbonyls by Transmetalation Reaction with Zinc Derivatives\n", "journal": "American Chemical\nSociety", "date": "2012.07", "author_list": ["Lecina\nJ.", "Carrer\nA.", "A\u0301lvarez-Larena\nA.", "Mazzi\nU.", "Melendez-Alafort\nL.", "Suades\nJ."]}}